<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35875883</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1755-3245</ISSN><JournalIssue CitedMedium="Internet"><Volume>119</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>31</Day></PubDate></JournalIssue><Title>Cardiovascular research</Title><ISOAbbreviation>Cardiovasc Res</ISOAbbreviation></Journal><ArticleTitle>Long COVID and the cardiovascular system-elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases.</ArticleTitle><Pagination><StartPage>336</StartPage><EndPage>356</EndPage><MedlinePgn>336-356</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/cvr/cvac115</ELocationID><Abstract><AbstractText>Long COVID has become a world-wide, non-communicable epidemic, caused by long-lasting multiorgan symptoms that endure for weeks or months after SARS-CoV-2 infection has already subsided. This scientific document aims to provide insight into the possible causes and therapeutic options available for the cardiovascular manifestations of long COVID. In addition to chronic fatigue, which is a common symptom of long COVID, patients may present with chest pain, ECG abnormalities, postural orthostatic tachycardia, or newly developed supraventricular or ventricular arrhythmias. Imaging of the heart and vessels has provided evidence of chronic, post-infectious perimyocarditis with consequent left or right ventricular failure, arterial wall inflammation, or microthrombosis in certain patient populations. Better understanding of the underlying cellular and molecular mechanisms of long COVID will aid in the development of effective treatment strategies for its cardiovascular manifestations. A number of mechanisms have been proposed, including those involving direct effects on the myocardium, microthrombotic damage to vessels or endothelium, or persistent inflammation. Unfortunately, existing circulating biomarkers, coagulation, and inflammatory markers, are not highly predictive for either the presence or outcome of long COVID when measured 3 months after SARS-CoV-2 infection. Further studies are needed to understand underlying mechanisms, identify specific biomarkers, and guide future preventive strategies or treatments to address long COVID and its cardiovascular sequelae.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gy&#xf6;ngy&#xf6;si</LastName><ForeName>Mariann</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Cardiology, 2nd Department of Internal Medicine, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alcaide</LastName><ForeName>Pilar</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Immunology, Tufts University School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asselbergs</LastName><ForeName>Folkert W</ForeName><Initials>FW</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Division Heart &amp; Lungs, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Data Research UK and Institute of Health Informatics, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brundel</LastName><ForeName>Bianca J J M</ForeName><Initials>BJJM</Initials><AffiliationInfo><Affiliation>Department of Physiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Vrije Universiteit Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camici</LastName><ForeName>Giovanni G</ForeName><Initials>GG</Initials><AffiliationInfo><Affiliation>Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, University Heart Center, University Hospital, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martins</LastName><ForeName>Paula da Costa</ForeName><Initials>PDC</Initials><Identifier Source="ORCID">0000-0002-0695-1187</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, CARIM School for Cardiovascular Diseases, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Genetics, Faculty of Sciences and Engineering, Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferdinandy</LastName><ForeName>P&#xe9;ter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pharmahungary Group, Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fontana</LastName><ForeName>Marianna</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9233-9831</Identifier><AffiliationInfo><Affiliation>Division of Medicine, Royal Free Hospital London, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Girao</LastName><ForeName>Henrique</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-5786-8447</Identifier><AffiliationInfo><Affiliation>Center for Innovative Biomedicine and Biotechnology (CIBB), Clinical Academic Centre of Coimbra (CACC), Faculty of Medicine, Univ Coimbra, Institute for Clinical and Biomedical Research (iCBR), Coimbra, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gnecchi</LastName><ForeName>Massimiliano</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-7435-4328</Identifier><AffiliationInfo><Affiliation>Department of Molecular Medicine, Unit of Cardiology, University of Pavia, Pavia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unit of Translational Cardiology, Division of Cardiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gollmann-Tepek&#xf6;yl&#xfc;</LastName><ForeName>Can</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kleinbongard</LastName><ForeName>Petra</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-3576-3772</Identifier><AffiliationInfo><Affiliation>Institut f&#xfc;r Pathophysiologie, Westdeutsches Herz- und Gef&#xe4;&#xdf;zentrum, Universit&#xe4;tsklinikum Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krieg</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-5192-580X</Identifier><AffiliationInfo><Affiliation>Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madonna</LastName><ForeName>Rosalinda</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pathology, Institute of Cardiology, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paillard</LastName><ForeName>Melanie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratoire CarMeN-&#xe9;quipe IRIS, INSERM, INRA, Universit&#xe9; Claude Bernard Lyon-1, INSA-Lyon, Univ-Lyon, 69500 Bron, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pantazis</LastName><ForeName>Antonis</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiovascular Research Centre at Royal Brompton and Harefield Hospitals, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perrino</LastName><ForeName>Cinzia</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-2274-0048</Identifier><AffiliationInfo><Affiliation>Department of Advanced Biomedical Sciences, Federico II University, Via Pansini 5, 80131 Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pesce</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3097-8961</Identifier><AffiliationInfo><Affiliation>Unit&#xe0; di Ingegneria Tissutale cardiovascolare, Centro Cardiologico Monzino, IRCCS, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schiattarella</LastName><ForeName>Gabriele G</ForeName><Initials>GG</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Cardiovascular Research (CCR), Department of Cardiology, Charit&#xe9;-Universit&#xe4;tsmedizin Berlin, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational Approaches in Heart Failure and Cardiometabolic Disease, Max Delbr&#xfc;ck Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sluijter</LastName><ForeName>Joost P G</ForeName><Initials>JPG</Initials><Identifier Source="ORCID">0000-0003-2088-9102</Identifier><AffiliationInfo><Affiliation>Laboratory of Experimental Cardiology, Cardiology, UMC Utrecht Regenerative Medicine Center, Utrecht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Circulatory Health Laboratory, Utrecht University, University Medical Center Utrecht, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steffens</LastName><ForeName>Sabine</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-6892-9751</Identifier><AffiliationInfo><Affiliation>Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximilians-Universit&#xe4;t, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Germany and Munich Heart Alliance, DZHK Partner Site Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsch&#xf6;pe</LastName><ForeName>Carsten</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Berlin Institute of Health (BIH) at Charit&#xe9;, Universit&#xe4;tmedizin Berlin, BIH Center for Regenerative Therapies (BCRT), German Center for Cardiovascular Research (DZHK), Partner site Berlin and Dept Cardiology (CVK), Charit&#xe9;, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Linthout</LastName><ForeName>Sophie</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-7581-7870</Identifier><AffiliationInfo><Affiliation>Berlin Institute of Health (BIH) at Charit&#xe9;, Universit&#xe4;tmedizin Berlin, BIH Center for Regenerative Therapies (BCRT), German Center for Cardiovascular Research (DZHK), Partner site Berlin and Dept Cardiology (CVK), Charit&#xe9;, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davidson</LastName><ForeName>Sean M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, WC1E 6HX London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>725229</GrantID><Acronym>ERC_</Acronym><Agency>European Research Council</Agency><Country>International</Country></Grant><Grant><GrantID>PG/16/85/32471</GrantID><Acronym>BHF_</Acronym><Agency>British Heart Foundation</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>PG/19/51/34493</GrantID><Acronym>BHF_</Acronym><Agency>British Heart Foundation</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>R01 HL144477</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cardiovasc Res</MedlineTA><NlmUniqueID>0077427</NlmUniqueID><ISSNLinking>0008-6363</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006321" MajorTopicYN="N">Heart</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006331" MajorTopicYN="Y">Heart Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009206" MajorTopicYN="N">Myocardium</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cardiac</Keyword><Keyword MajorTopicYN="N">Cardiovascular</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Post COVID</Keyword></KeywordList><CoiStatement>Conflict of interest: F.W.A., P.A., B.J.J.M.B., S.M.D., M.F., M.G., S.V.L., R.M., C.P., M.P., G.G.S., S.S., C.G.-T., T.K.: no conflicts to disclose. G.G.C. is coinventors on the International Patent WO/2020/226993 filed in April 2020. The patent relates to the use of antibodies which specifically bind IL-1&#x3b1; to reduce various sequelae of ischaemia-reperfusion injury to the central nervous system. G.G.C. is a consultant to Sovida solutions limited. P.F. is the founder and CEO of Pharmahungary Group, a group of R&amp;D companies. C.T. has received speaker fees and/or contributions to congresses from Abbott, Abiomed, Astra Zeneca, Bayer, B&#xf6;hringer-Ingelheim, Novartis, Pfizer, and Servier; all outside the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>25</Day><Hour>4</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35875883</ArticleId><ArticleId IdType="pmc">PMC9384470</ArticleId><ArticleId IdType="doi">10.1093/cvr/cvac115</ArticleId><ArticleId IdType="pii">6649450</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Worldometers.info . Worldometers. Dover, Delaware, USA; 2021.</Citation></Reference><Reference><Citation>Ahmad FB, Anderson RN. The leading causes of death in the US for 2020. JAMA 2021;325:1829&#x2013;1830.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8145781</ArticleId><ArticleId IdType="pubmed">33787821</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlinsky A, Kobak D. Tracking excess mortality across countries during the COVID-19 pandemic with the world mortality dataset. Elife 2021;10:e69336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8331176</ArticleId><ArticleId IdType="pubmed">34190045</ArticleId></ArticleIdList></Reference><Reference><Citation>Troeger C. Just how do deaths due to COVID-19 stack up?: Think Gloval Health; 2021.</Citation></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, Pujol JC, Klaser K, Antonelli M, Canas LS, Molteni E, Modat M, Jorge Cardoso M, May A, Ganesh S, Davies R, Nguyen LH, Drew DA, Astley CM, Joshi AD, Merino J, Tsereteli N, Fall T, Gomez MF, Duncan EL, Menni C, Williams FMK, Franks PW, Chan AT, Wolf J, Ourselin S, Spector T, Steves CJ. Attributes and predictors of long COVID. Nat Med 2021;27:626&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B, Mohn KG, Brokstad KA, Zhou F, Linchausen DW, Hansen BA, Lartey S, Onyango TB, Kuwelker K, Saevik M, Bartsch H, Tondel C, Kittang BR, Bergen C-RG, Cox RJ, Langeland N. Long COVID in a prospective cohort of home-isolated patients. Nat Med 2021;27:1607&#x2013;1613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefano GB. Historical insight into infections and disorders associated with neurological and psychiatric sequelae similar to long COVID. Med Sci Monit 2021;27:e931447.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7924007</ArticleId><ArticleId IdType="pubmed">33633106</ArticleId></ArticleIdList></Reference><Reference><Citation>Honigsbaum M, Krishnan L. Taking pandemic sequelae seriously: from the Russian influenza to COVID-19 long-haulers. Lancet 2020;396:1389&#x2013;1391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7550169</ArticleId><ArticleId IdType="pubmed">33058777</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-Month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry 2021;8:416&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, Kang L, Guo L, Liu M, Zhou X, Luo J, Huang Z, Tu S, Zhao Y, Chen L, Xu D, Li Y, Li C, Peng L, Li Y, Xie W, Cui D, Shang L, Fan G, Xu J, Wang G, Wang Y, Zhong J, Wang C, Wang J, Zhang D, Cao B. 6-Month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 2021;397:220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosn J, Piroth L, Epaulard O, Le Turnier P, Mentre F, Bachelet D, Laouenan C, French COVID cohort study and investigators groups . Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort. Clin Microbiol Infect 2021;27:1041.e1&#x2013;1041.e4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8107834</ArticleId><ArticleId IdType="pubmed">34125067</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med 2021;18:e1003773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE, Brown JS, Denneny EK, Hare SS, Heightman M, Hillman TE, Jacob J, Jarvis HC, Lipman MCI, Naidu SB, Nair A, Porter JC, Tomlinson GS, Hurst JR. &#x2018;Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax 2021;76:396&#x2013;398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Heesakkers H, van der Hoeven JG, Corsten S, Janssen I, Ewalds E, Simons KS, Westerhof B, Rettig TCD, Jacobs C, van Santen S, Slooter AJC, van der Woude MCE, van den Boogaard M, Zegers M. Clinical outcomes among patients with 1-year survival following intensive care unit treatment for COVID-19. JAMA 2022;327:559&#x2013;565.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8787680</ArticleId><ArticleId IdType="pubmed">35072716</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore JP, Offit PA. SARS-CoV-2 vaccines and the growing threat of viral variants. JAMA 2021;325:821&#x2013;822.</Citation><ArticleIdList><ArticleId IdType="pubmed">33507218</ArticleId></ArticleIdList></Reference><Reference><Citation>Statista. 7-Day incidence of corona infections (COVID-19) in Germany by age group in 2021.</Citation></Reference><Reference><Citation>Khoury J, Najjar-Debbiny R, Hanna A, Jabbour A, Abu Ahmad Y, Saffuri A, Abu-Sinni M, Shkeiri R, Elemy A, Hakim F. COVID-19 vaccine&#x2014;long term immune decline and breakthrough infections. Vaccine 2021;39:6984&#x2013;6989.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8556595</ArticleId><ArticleId IdType="pubmed">34763949</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med 2022;28:583&#x2013;590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Satterfield BA, Bhatt DL, Gersh BJ. Cardiac involvement in the long-term implications of COVID-19. Nat Rev Cardiol 2022;19:332&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8532434</ArticleId><ArticleId IdType="pubmed">34686843</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, Gibbs KW, Erickson HL, Steingrub JS, Smithline HA, Gong MN, Aboodi MS, Exline MC, Henning DJ, Wilson JG, Khan A, Qadir N, Brown SM, Peltan ID, Rice TW, Hager DN, Ginde AA, Stubblefield WB, Patel MM, Self WH, Feldstein LR. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network&#x2014;United States, March&#x2013;June 2020. Morb Mortal Wkly Rep 2020;69:993&#x2013;998.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A'Court C, Buxton M, Husain L. Management of post-acute COVID-19 in primary care. BMJ 2020;370:m3026.</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera JE, Niehaus WN, Whiteson J, Azola A, Baratta JM, Fleming TK, Kim SY, Naqvi H, Sampsel S, Silver JK, Gutierrez MV, Maley J, Herman E, Abramoff B. Multidisciplinary collaborative consensus guidance statement on the assessment and treatment of fatigue in postacute sequelae of SARS-CoV-2 infection (PASC) patients. PM R 2021;13:1027&#x2013;1043.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8441628</ArticleId><ArticleId IdType="pubmed">34346558</ArticleId></ArticleIdList></Reference><Reference><Citation>(UK) NIfHaCE. COVID-19 rapid guideline: managing the long-term effects of COVID-19 . COVID-19 rapid guideline: managing the long-term effects of COVID-19. London; 2020.</Citation></Reference><Reference><Citation>Kamal M, Abo Omirah M, Hussein A, Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract 2021;75:e13746.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7536922</ArticleId><ArticleId IdType="pubmed">32991035</ArticleId></ArticleIdList></Reference><Reference><Citation>Kayaaslan B, Eser F, Kalem AK, Kaya G, Kaplan B, Kacar D, Hasanoglu I, Coskun B, Guner R. Post-COVID syndrome: a single-center questionnaire study on 1007 participants recovered from COVID-19. J Med Virol 2021;93:6566&#x2013;6574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8426910</ArticleId><ArticleId IdType="pubmed">34255355</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones R, Davis A, Stanley B, Julious S, Ryan D, Jackson DJ, Halpin DMG, Hickman K, Pinnock H, Quint JK, Khunti K, Heaney LG, Oliver P, Siddiqui S, Pavord I, Jones DHM, Hyland M, Ritchie L, Young P, Megaw T, Davis S, Walker S, Holgate S, Beecroft S, Kemppinen A, Appiagyei F, Roberts EJ, Preston M, Hardjojo A, Carter V, van Melle M, Price D. Risk predictors and symptom features of long COVID within a broad primary care patient population including both tested and untested patients. Pragmat Obs Res 2021;12:93&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8366779</ArticleId><ArticleId IdType="pubmed">34408531</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotecha T, Knight DS, Razvi Y, Kumar K, Vimalesvaran K, Thornton G, Patel R, Chacko L, Brown JT, Coyle C, Leith D, Shetye A, Ariff B, Bell R, Captur G, Coleman M, Goldring J, Gopalan D, Heightman M, Hillman T, Howard L, Jacobs M, Jeetley PS, Kanagaratnam P, Kon OM, Lamb LE, Manisty CH, Mathurdas P, Mayet J, Negus R, Patel N, Pierce I, Russell G, Wolff A, Xue H, Kellman P, Moon JC, Treibel TA, Cole GD, Fontana M. Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. Eur Heart J 2021;42:1866&#x2013;1878.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7928984</ArticleId><ArticleId IdType="pubmed">33596594</ArticleId></ArticleIdList></Reference><Reference><Citation>Jesuthasan A, Massey F, Manji H, Zandi MS, Wiethoff S. Emerging potential mechanisms and predispositions to the neurological manifestations of COVID-19. J Neurol Sci 2021;428:117608.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8332920</ArticleId><ArticleId IdType="pubmed">34391037</ArticleId></ArticleIdList></Reference><Reference><Citation>Torjesen I. COVID-19: middle aged women face greater risk of debilitating long term symptoms. BMJ 2021;372:n829.</Citation><ArticleIdList><ArticleId IdType="pubmed">33766927</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long COVID-mechanisms, risk factors, and management. BMJ 2021;374:n1648.</Citation><ArticleIdList><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M, Schommers P, Stecher M, Dewald F, Gieselmann L, Gruell H, Horn C, Vanshylla K, Cristanziano VD, Osebold L, Roventa M, Riaz T, Tschernoster N, Altmueller J, Rose L, Salomon S, Priesner V, Luers JC, Albus C, Rosenkranz S, Gathof B, F&#xe4;tkenheuer G, Hallek M, Klein F, Su&#xe1;rez I, Lehmann C. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur 2021;6:100122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia C, Zurbuchen Y, Taeschler P, Ballouz T, Menges D, Hasler S, Adamo S, Raeber ME, B&#xe4;chli E, Rudiger A, St&#xfc;ssi-Helbling M, Huber LC, Nilsson J, Held U, Puhan MA, Boyman O. Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome. Nat Commun 2022;13:446.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8789854</ArticleId><ArticleId IdType="pubmed">35078982</ArticleId></ArticleIdList></Reference><Reference><Citation>Paterson I, Ramanathan K, Aurora R, Bewick D, Chow CM, Clarke B, Cowan S, Ducharme A, Gin K, Graham M, Gupta A, Jassal DS, Kazmi M, Krahn A, Lamarche Y, Marelli A, Roifman I, Ruel M, Singh G, Sterns L, Turgeon R, Virani S, Wong KK, Zieroth S. Long COVID-19: a primer for cardiovascular health professionals, on behalf of the CCS rapid response team. Can J Cardiol 2021;37:1260&#x2013;1262.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8180343</ArticleId><ArticleId IdType="pubmed">34090980</ArticleId></ArticleIdList></Reference><Reference><Citation>Siso-Almirall A, Brito-Zeron P, Conangla Ferrin L, Kostov B, Moragas Moreno A, Mestres J, Sellares J, Galindo G, Morera R, Basora J, Trilla A, Ramos-Casals M, On Behalf Of The CLC-SG . Long COVID-19: proposed primary care clinical guidelines for diagnosis and disease management. Int J Environ Res Public Health 2021;18:4350.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8073248</ArticleId><ArticleId IdType="pubmed">33923972</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarfraz Z, Sarfraz A, Barrios A, Garimella R, Dominari A, Kc M, Pandav K, Pantoja JC, Retnakumar V, Cherrez-Ojeda I. Cardio-pulmonary sequelae in recovered COVID-19 patients: considerations for primary care. J Prim Care Commun Health 2021;12:21501327211023726.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8188976</ArticleId><ArticleId IdType="pubmed">34096390</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter D, Guasti L, Koehler F, Squizzato A, Nistri S, Christodorescu R, Dievart F, Gaudio G, Asteggiano R, Ferrini M. Late phase of COVID-19 pandemic in general cardiology. A position paper of the ESC council for cardiology practice. ESC Heart Fail 2021;8:3483&#x2013;3494.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8427022</ArticleId><ArticleId IdType="pubmed">34170086</ArticleId></ArticleIdList></Reference><Reference><Citation>Cau R, Faa G, Nardi V, Balestrieri A, Puig J, Suri JS, SanFilippo R, Saba L. Long-COVID diagnosis: from diagnostic to advanced AI-driven models. Eur J Radiol 2022;148:110164.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8791239</ArticleId><ArticleId IdType="pubmed">35114535</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghram A, Ayadi H, Knechtle B, Ben Saad H. What should a family physician know about nutrition and physical exercise rehabilitation&#x2019; advices to communicate to &#x2018;long-term COVID-19&#x2019; patients? Postgrad Med 2022;134:143&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pubmed">35083948</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Jain V, Singh A. Stacking ensemble-based intelligent machine learning model for predicting post-COVID-19 complications. New Gener Comput 2021:1&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8669670</ArticleId><ArticleId IdType="pubmed">34924675</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossain MA, Hossain KMA, Saunders K, Uddin Z, Walton LM, Raigangar V, Sakel M, Shafin R, Hossain MS, Kabir MF, Faruqui R, Rana MS, Ahmed MS, Chakrovorty SK, Hossain MA, Jahid IK. Prevalence of long COVID symptoms in Bangladesh: a prospective inception cohort study of COVID-19 survivors. BMJ Glob Health 2021;6:e006838.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8671853</ArticleId><ArticleId IdType="pubmed">34906986</ArticleId></ArticleIdList></Reference><Reference><Citation>Fine JS, Ambrose AF, Didehbani N, Fleming TK, Glashan L, Longo M, Merlino A, Ng R, Nora GJ, Rolin S, Silver JK, Terzic CM, Verduzco-Gutierrez M, Sampsel S. Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of cognitive symptoms in patients with post-acute sequelae of SARS-CoV-2 infection (PASC). PM R 2022;14:96&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pubmed">34902226</ArticleId></ArticleIdList></Reference><Reference><Citation>Narula N, Singh HS. Cardiology practice and training post-COVID-19: achieving &#x201c;normalcy&#x201d; after disruption. J Am Coll Cardiol 2020;76:476&#x2013;479.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7307979</ArticleId><ArticleId IdType="pubmed">32703519</ArticleId></ArticleIdList></Reference><Reference><Citation>Dweck MR, Bularga A, Hahn RT, Bing R, Lee KK, Chapman AR, White A, Salvo GD, Sade LE, Pearce K, Newby DE, Popescu BA, Donal E, Cosyns B, Edvardsen T, Mills NL, Haugaa K. Global evaluation of echocardiography in patients with COVID-19. Eur Heart J Cardiovasc Imaging 2020;21:949&#x2013;958.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7337658</ArticleId><ArticleId IdType="pubmed">32556199</ArticleId></ArticleIdList></Reference><Reference><Citation>Cenko E, Badimon L, Bugiardini R, Claeys MJ, De Luca G, de Wit C, Derumeaux G, Dorobantu M, Duncker DJ, Eringa EC, Gorog DA, Hassager C, Heinzel FR, Huber K, Manfrini O, Milicic D, Oikonomou E, Padro T, Trifunovic-Zamaklar D, Vasiljevic-Pokrajcic Z, Vavlukis M, Vilahur G, Tousoulis D. Cardiovascular disease and COVID-19: a consensus paper from the ESC working group on coronary pathophysiology &amp; microcirculation, ESC working group on thrombosis and the association for acute CardioVascular care (ACVC), in collaboration with the European heart rhythm association (EHRA). Cardiovasc Res 2021;117:2705&#x2013;2729.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8500019</ArticleId><ArticleId IdType="pubmed">34528075</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Toro A, Bozzani A, Tavazzi G, Urtis M, Giuliani L, Pizzoccheri R, Aliberti F, Fergnani V, Arbustini E. Long COVID: long-term effects? Eur Heart J Suppl 2021;23:E1&#x2013;E5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8503490</ArticleId><ArticleId IdType="pubmed">34650349</ArticleId></ArticleIdList></Reference><Reference><Citation>Maestre-Muniz MM, Arias A, Mata-Vazquez E, Martin-Toledano M, Lopez-Larramona G, Ruiz-Chicote AM, Nieto-Sandoval B, Lucendo AJ. Long-term outcomes of patients with coronavirus disease 2019 at one year after hospital discharge. J Clin Med 2021;10:2945.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8269002</ArticleId><ArticleId IdType="pubmed">34209085</ArticleId></ArticleIdList></Reference><Reference><Citation>Szekely Y, Lichter Y, Sadon S, Lupu L, Taieb P, Banai A, Sapir O, Granot Y, Hochstadt A, Friedman S, Laufer-Perl M, Banai S, Topilsky Y. Cardiorespiratory abnormalities in patients recovering from COVID-19. J Am Soc Echocardiogr 2021;34:1273&#x2013;1284.e9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8425293</ArticleId><ArticleId IdType="pubmed">34508837</ArticleId></ArticleIdList></Reference><Reference><Citation>Oronsky B, Larson C, Hammond TC, Oronsky A, Kesari S, Lybeck M, Reid TR. A review of persistent post-COVID syndrome (PPCS). Clin Rev Allergy Immunol 2021:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7896544</ArticleId><ArticleId IdType="pubmed">33609255</ArticleId></ArticleIdList></Reference><Reference><Citation>Asarcikli LD, Hayiroglu MI, Osken A, Keskin K, Kolak Z, Aksu T. Heart rate variability and cardiac autonomic functions in post-COVID period. J Interv Card Electrophysiol 2022;63:715&#x2013;721.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8806134</ArticleId><ArticleId IdType="pubmed">35106678</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramadan MS, Bertolino L, Zampino R, Durante-Mangoni E, Monaldi Hospital Cardiovascular Infection Study Group . Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review. Clin Microbiol Infect 2021; 27:1250&#x2013;1261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8220864</ArticleId><ArticleId IdType="pubmed">34171458</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan BE, Umapathi T, Chua K, Chia YW, Wong SW, Tan GWL, Chandrasekar S, Lum YH, Vasoo S, Dalan R. Delayed catastrophic thrombotic events in young and asymptomatic post COVID-19 patients. J Thromb Thrombolysis 2021;51:971&#x2013;977.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7648538</ArticleId><ArticleId IdType="pubmed">33159640</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall J, Myall K, Lam JL, Mason T, Mukherjee B, West A, Dewar A. Identifying patients at risk of post-discharge complications related to COVID-19 infection. Thorax 2021;76:408&#x2013;411.</Citation><ArticleIdList><ArticleId IdType="pubmed">33542090</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber B, Siddiqi H, Zhou G, Vieira J, Kim A, Rutherford H, Mitre X, Feeley M, Oganezova K, Varshney AS, Bhatt AS, Nauffal V, Atri DS, Blankstein R, Karlson EW, Di Carli M, Baden LR, Bhatt DL, Woolley AE. Relationship between myocardial injury during index hospitalization for SARS-CoV-2 infection and longer-term outcomes. J Am Heart Assoc 2022;11:e022010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9075193</ArticleId><ArticleId IdType="pubmed">34970914</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewek J, Jatczak-Pawlik I, Maciejewski M, Jankowski P, Banach M. COVID-19 and cardiovascular complications&#x2014;preliminary results of the LATE-COVID study. Arch Med Sci 2021;17:818&#x2013;822.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8130484</ArticleId><ArticleId IdType="pubmed">34025853</ArticleId></ArticleIdList></Reference><Reference><Citation>Moulson N, Petek BJ, Drezner JA, Harmon KG, Kliethermes SA, Patel MR, Baggish AL, Outcomes Registry for Cardiac Conditions in Athletes Investigators . SARS-CoV-2 cardiac involvement in young competitive athletes. Circulation 2021; 144:256&#x2013;266.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8300154</ArticleId><ArticleId IdType="pubmed">33866822</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M, Dirksen A, Taraborrelli P, Torocastro M, Panagopoulos D, Sutton R, Lim PB. Autonomic dysfunction in &#x2018;long COVID': rationale, physiology and management strategies. Clin Med 2021;21:e63&#x2013;e67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Moody WE, Liu B, Mahmoud-Elsayed HM, Senior J, Lalla SS, Khan-Kheil AM, Brown S, Saif A, Moss A, Bradlow WM, Khoo J, Ahamed M, McAloon C, Hothi SS, Steeds RP. Persisting adverse ventricular remodeling in COVID-19 survivors: a longitudinal echocardiographic study. J Am Soc Echocardiogr 2021;34:562&#x2013;566.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8008825</ArticleId><ArticleId IdType="pubmed">33539950</ArticleId></ArticleIdList></Reference><Reference><Citation>Sechi LA, Colussi G, Bulfone L, Brosolo G, Da Porto A, Peghin M, Patruno V, Tascini C, Catena C. Short-term cardiac outcome in survivors of COVID-19: a systematic study after hospital discharge. Clin Res Cardiol 2021;110:1063&#x2013;1072.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7820534</ArticleId><ArticleId IdType="pubmed">33481096</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassen MCH, Skaarup KG, Lind JN, Alhakak AS, Sengelov M, Nielsen AB, Simonsen JO, Johansen ND, Davidovski FS, Christensen J, Bundgaard H, Hassager C, Jabbari R, Carlsen J, Kirk O, Lindholm MG, Kristiansen OP, Nielsen OW, Ulrik CS, Sivapalan P, Gislason G, Mogelvang R, Jensen GB, Schnohr P, Sogaard P, Solomon SD, Iversen K, Jensen JUS, Schou M, Biering-Sorensen T. Recovery of cardiac function following COVID-19&#x2014;ECHOVID-19: a prospective longitudinal cohort study. Eur J Heart Fail 2021;23:1903&#x2013;1912.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8652600</ArticleId><ArticleId IdType="pubmed">34514713</ArticleId></ArticleIdList></Reference><Reference><Citation>Tudoran C, Tudoran M, Pop GN, Giurgi-Oncu C, Cut TG, Lazureanu VE, Oancea C, Parv F, Ciocarlie T, Bende F. Associations between the severity of the post-acute COVID-19 syndrome and echocardiographic abnormalities in previously healthy outpatients following infection with SARS-CoV-2. Biology (Basel) 2021;10:469.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8226755</ArticleId><ArticleId IdType="pubmed">34073342</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghugre NR, Orbach A, Biswas L, Connelly KA, Chan A, Strauss BH, Wright GA, Roifman I. Suspected subclinical myocarditis detected by cardiac magnetic resonance imaging late post COVID-19 recovery. J Cardiol Cases 2021;24:203&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8120449</ArticleId><ArticleId IdType="pubmed">34007346</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Zhao P, Tang D, Zhu T, Han R, Zhan C, Liu W, Zeng H, Tao Q, Xia L. Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging. JACC Cardiovasc Imaging 2020;13:2330&#x2013;2339.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7214335</ArticleId><ArticleId IdType="pubmed">32763118</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, Shchendrygina A, Escher F, Vasa-Nicotera M, Zeiher AM, Vehreschild M, Nagel E. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020;5:1265&#x2013;1273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulloa J U, de Vega V M, Montanes O S, Vazquez A A, Sanchez-Enrique C, Hernandez Jimenez S, Sancho Garcia FD, Lopez Ruiz L, Recio Rodriguez M, Pizarro G, Carnevali Ruiz D, Angel Cabrera J. Cardiac magnetic resonance in recovering COVID-19 patients. Feature tracking and mapping analysis to detect persistent myocardial involvement. Int J Cardiol Heart Vasc 2021;36:100854.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8328575</ArticleId><ArticleId IdType="pubmed">34368419</ArticleId></ArticleIdList></Reference><Reference><Citation>Kravchenko D, Isaak A, Zimmer S, Mesropyan N, Reinert M, Faron A, Pieper CC, Heine A, Velten M, Nattermann J, Kuetting D, Duerr GD, Attenberger UI, Luetkens JA. Cardiac MRI in patients with prolonged cardiorespiratory symptoms after mild to moderate COVID-19 infection. Radiology 2021;301:E419&#x2013;E425.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8369880</ArticleId><ArticleId IdType="pubmed">34374593</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato S, Azuma M, Fukui K, Kodama S, Nakayama N, Kitamura H, Hagiwara E, Ogura T, Horita N, Namkoong H, Kimura K, Tamura K, Utsunomiya D. Cardiac involvement in coronavirus disease 2019 assessed by cardiac magnetic resonance imaging: a meta-analysis. Heart Vessels 2022:1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8925980</ArticleId><ArticleId IdType="pubmed">35294611</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedrich MG, Cooper LT. What we (don't) know about myocardial injury after COVID-19. Eur Heart J 2021;42:1879&#x2013;1882.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8108615</ArticleId><ArticleId IdType="pubmed">33713116</ArticleId></ArticleIdList></Reference><Reference><Citation>Joy G, Artico J, Kurdi H, Seraphim A, Lau C, Thornton GD, Oliveira MF, Adam RD, Aziminia N, Menacho K, Chacko L, Brown JT, Patel RK, Shiwani H, Bhuva A, Augusto JB, Andiapen M, McKnight A, Noursadeghi M, Pierce I, Evain T, Captur G, Davies RH, Greenwood JP, Fontana M, Kellman P, Schelbert EB, Treibel TA, Manisty C, Moon JC. Prospective case&#x2013;control study of cardiovascular abnormalities 6 months following mild COVID-19 in healthcare workers. JACC Cardiovasc Imaging 2021;14:2155&#x2013;2166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8105493</ArticleId><ArticleId IdType="pubmed">33975819</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkbride RR, Rawal B, Mirsadraee S, Galperin-Aizenberg M, Wechalekar K, Ridge CA, Litmanovich DE. Imaging of cardiac infections: a comprehensive review and investigation flowchart for diagnostic workup. J Thorac Imaging 2021;36:W70&#x2013;W88.</Citation><ArticleIdList><ArticleId IdType="pubmed">32852420</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadkhodayan A, Chareonthaitawee P, Raman SV, Cooper LT. Imaging of inflammation in unexplained cardiomyopathy. JACC Cardiovasc Imaging 2016;9:603&#x2013;617.</Citation><ArticleIdList><ArticleId IdType="pubmed">27151523</ArticleId></ArticleIdList></Reference><Reference><Citation>Satapathy S, Kumar R, Kavanal AJ, Krishnaraju VS, Ramachandran A, Deo P, Dhir V, Mittal BR. COVID-19 related multisystem inflammatory syndrome in children (MIS-C): role of (18)F-FDG PET/CT to assess myocardial involvement. J Nucl Cardiol 2021:1&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7901863</ArticleId><ArticleId IdType="pubmed">33624189</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollini M, Ciccarelli M, Cecconi M, Aghemo A, Morelli P, Gelardi F, Chiti A. Vasculitis changes in COVID-19 survivors with persistent symptoms: an [(18)F]FDG-PET/CT study. Eur J Nucl Med Mol Imaging 2021;48:1460&#x2013;1466.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7595761</ArticleId><ArticleId IdType="pubmed">33123760</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollini M, Morbelli S, Ciccarelli M, Cecconi M, Aghemo A, Morelli P, Chiola S, Gelardi F, Chiti A. Long COVID hallmarks on [18F]FDG-PET/CT: a case&#x2013;control study. Eur J Nucl Med Mol Imaging 2021;48:3187&#x2013;3197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7937050</ArticleId><ArticleId IdType="pubmed">33677642</ArticleId></ArticleIdList></Reference><Reference><Citation>Saricam E, Dursun AD, Turkmen Sariyildiz G, Can N, Bozkurt E, Gonullu U, Basay N, Turkmen M, Denli A, Unlu M. Laboratory and imaging evaluation of cardiac involvement in patients with post-acute COVID-19. Int J Gen Med 2021;14:4977&#x2013;4985.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8412825</ArticleId><ArticleId IdType="pubmed">34511982</ArticleId></ArticleIdList></Reference><Reference><Citation>Strohbehn IA, Zhao S, Seethapathy H, Lee M, Rusibamayila N, Allegretti AS, Parada XV, Sise ME. Acute kidney injury incidence, recovery, and long-term kidney outcomes among hospitalized patients with COVID-19 and influenza. Kidney Int Rep 2021;6:2565&#x2013;2574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280679</ArticleId><ArticleId IdType="pubmed">34307971</ArticleId></ArticleIdList></Reference><Reference><Citation>Yende S, Parikh CR. Long COVID and kidney disease. Nat Rev Nephrol 2021;17:792&#x2013;793.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8427150</ArticleId><ArticleId IdType="pubmed">34504319</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens JS, King KL, Robbins-Juarez SY, Khairallah P, Toma K, Alvarado Verduzco H, Daniel E, Douglas D, Moses AA, Peleg Y, Starakiewicz P, Li MT, Kim DW, Yu K, Qian L, Shah VH, O'Donnell MR, Cummings MJ, Zucker J, Natarajan K, Perotte A, Tsapepas D, Krzysztof K, Dube G, Siddall E, Shirazian S, Nickolas TL, Rao MK, Barasch JM, Valeri AM, Radhakrishnan J, Gharavi AG, Husain SA, Mohan S. High rate of renal recovery in survivors of COVID-19 associated acute renal failure requiring renal replacement therapy. PLoS One 2020;15:e0244131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7769434</ArticleId><ArticleId IdType="pubmed">33370368</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C, Wang Z, Lorenzi JCC, Muecksch F, Finkin S, Tokuyama M, Cho A, Jankovic M, Schaefer-Babajew D, Oliveira TY, Cipolla M, Viant C, Barnes CO, Bram Y, Breton G, Hagglof T, Mendoza P, Hurley A, Turroja M, Gordon K, Millard KG, Ramos V, Schmidt F, Weisblum Y, Jha D, Tankelevich M, Martinez-Delgado G, Yee J, Patel R, Dizon J, Unson-O'Brien C, Shimeliovich I, Robbiani DF, Zhao Z, Gazumyan A, Schwartz RE, Hatziioannou T, Bjorkman PJ, Mehandru S, Bieniasz PD, Caskey M, Nussenzweig MC. Evolution of antibody immunity to SARS-CoV-2. Nature 2021;591:639&#x2013;644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund LC, Hallas J, Nielsen H, Koch A, Mogensen SH, Brun NC, Christiansen CF, Thomsen RW, Pottegard A. Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study. Lancet Infect Dis 2021;21:1373&#x2013;1382.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8110209</ArticleId><ArticleId IdType="pubmed">33984263</ArticleId></ArticleIdList></Reference><Reference><Citation>Albu S, Zozaya NR, Murillo N, Garcia-Molina A, Chacon CAF, Kumru H. What's going on following acute COVID-19? Clinical characteristics of patients in an out-patient rehabilitation program. NeuroRehabilitation 2021;48:469&#x2013;480.</Citation><ArticleIdList><ArticleId IdType="pubmed">33998551</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P, Bunker CB, Ciurtin C, Porter JC, Chambers RC, Papdopoulou C, Garthwaite H, Hillman T, Heightman M, Howell KJ, Eleftheriou D, Denton CP. Chilblain-like acral lesions in long COVID-19: management and implications for understanding microangiopathy. Lancet Infect Dis 2021;21:912.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8221732</ArticleId><ArticleId IdType="pubmed">33705725</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeo I, Baek S, Kim J, Elshakh H, Voronina A, Lou MS, Vapnik J, Kaler R, Dai X, Goldbarg S. Assessment of thirty-day readmission rate, timing, causes and predictors after hospitalization with COVID-19. J Intern Med 2021;290:157&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8013754</ArticleId><ArticleId IdType="pubmed">33452824</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Khunti K, Nafilyan V, Maddox T, Humberstone B, Diamond I, Banerjee A. Post-COVID syndrome in individuals admitted to hospital with COVID-19: retrospective cohort study. BMJ 2021;372:n693.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicol M, Cacoub L, Baudet M, Nahmani Y, Cacoub P, Cohen-Solal A, Henry P, Adle-Biassette H, Logeart D. Delayed acute myocarditis and COVID-19-related multisystem inflammatory syndrome. ESC Heart Fail 2020;7:4371&#x2013;4376.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7755006</ArticleId><ArticleId IdType="pubmed">33107217</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Falahi Z, Al-Harthi S, Farhan H, Al Busaidi I, Al Alawi AM. Late-onset COVID-19-related multi-system inflammatory syndrome in a middle-aged man. Cureus 2021;13:e15855.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8301271</ArticleId><ArticleId IdType="pubmed">34327082</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L, Tang K, Levin M, Irfan O, Morris SK, Wilson K, Klein JD, Bhutta ZA. COVID-19 and multisystem inflammatory syndrome in children and adolescents. Lancet Infect Dis 2020;20:e276&#x2013;e288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7431129</ArticleId><ArticleId IdType="pubmed">32818434</ArticleId></ArticleIdList></Reference><Reference><Citation>Belay ED, Abrams J, Oster ME, Giovanni J, Pierce T, Meng L, Prezzato E, Balachandran N, Openshaw JJ, Rosen HE, Kim M, Richardson G, Hand J, Tobin-D'Angelo M, Wilson S, Hartley A, Jones C, Kolsin J, Mohamed H, Colles Z, Hammett T, Patel P, Stierman B, Campbell AP, Godfred-Cato S. Trends in geographic and temporal distribution of US children with multisystem inflammatory syndrome during the COVID-19 pandemic. JAMA Pediatr 2021;175:837&#x2013;845.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8025123</ArticleId><ArticleId IdType="pubmed">33821923</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P, Ramnarayan P, Fraisse A, Miller O, Davies P, Kucera F, Brierley J, McDougall M, Carter M, Tremoulet A, Shimizu C, Herberg J, Burns JC, Lyall H, Levin M, Group P-TS, Euclids CP. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA 2020;324:259&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7281356</ArticleId><ArticleId IdType="pubmed">32511692</ArticleId></ArticleIdList></Reference><Reference><Citation>Syrimi E, Fennell E, Richter A, Vrljicak P, Stark R, Ott S, Murray PG, Al-Abadi E, Chikermane A, Dawson P, Hackett S, Jyothish D, Kanthimathinathan HK, Monaghan S, Nagakumar P, Scholefield BR, Welch S, Khan N, Faustini S, Davies K, Zelek WM, Kearns P, Taylor GS. The immune landscape of SARS-CoV-2-associated multisystem inflammatory syndrome in children (MIS-C) from acute disease to recovery. iScience 2021;24:103215.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8487319</ArticleId><ArticleId IdType="pubmed">34632327</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L, Cevik M, Jesudason E, Lim WS, Rello J, Amuasi J, Bozza F, Palmieri C, Munblit D, Holter JC, Kildal AB, Reyes LF, Russell CD, Ho A, Turtle L, Drake TM, Beltrame A, Hann K, Bangura IR, Fowler R, Lakoh S, Berry C, Lowe DJ, McPeake J, Hashmi M, Dyrhol-Riise AM, Donohue C, Plotkin D, Hardwick H, Elkheir N, Lone NI, Docherty A, Harrison E, Baille JK, Carson G, Semple MG, Scott JT. What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocol. BMJ Open 2021;11:e043887.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7948153</ArticleId><ArticleId IdType="pubmed">33692181</ArticleId></ArticleIdList></Reference><Reference><Citation>Horn A, Krist L, Lieb W, Montellano FA, Kohls M, Haas K, Gelbrich G, Bolay-Gehrig SJ, Morbach C, Reese JP, Stork S, Fricke J, Zoller T, Schmidt S, Triller P, Kretzler L, Ronnefarth M, Von Kalle C, Willich SN, Kurth F, Steinbeis F, Witzenrath M, Bahmer T, Hermes A, Krawczak M, Reinke L, Maetzler C, Franzenburg J, Enderle J, Flinspach A, Vehreschild J, Schons M, Illig T, Anton G, Ungethum K, Finkenberg BC, Gehrig MT, Savaskan N, Heuschmann PU, Keil T, Schreiber S. Long-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP). Infection 2021;49:1277&#x2013;1287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8508400</ArticleId><ArticleId IdType="pubmed">34642875</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, Rodrigues NB, Subramaniapillai M, Di Vincenzo JD, Cao B, Lin K, Mansur RB, Ho RC, Rosenblat JD, Miskowiak KW, Vinberg M, Maletic V, McIntyre RS. Fatigue and cognitive impairment in post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav Immun 2022;101:93&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Laing AG, Lorenc A, Del Barrio I DM, Das A, Fish M, Monin L, Munoz-Ruiz M, McKenzie DR, Hayday TS, Francos-Quijorna I, Kamdar S, Joseph M, Davies D, Davis R, Jennings A, Zlatareva I, Vantourout P, Wu Y, Sofra V, Cano F, Greco M, Theodoridis E, Freedman JD, Gee S, Chan JNE, Ryan S, Bugallo-Blanco E, Peterson P, Kisand K, Haljasmagi L, Chadli L, Moingeon P, Martinez L, Merrick B, Bisnauthsing K, Brooks K, Ibrahim MAA, Mason J, Lopez Gomez F, Babalola K, Abdul-Jawad S, Cason J, Mant C, Seow J, Graham C, Doores KJ, Di Rosa F, Edgeworth J, Shankar-Hari M, Hayday AC. A dynamic COVID-19 immune signature includes associations with poor prognosis. Nat Med 2020;26:1623&#x2013;1635.</Citation><ArticleIdList><ArticleId IdType="pubmed">32807934</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond) 2021;53:737&#x2013;754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, Villapol S. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep 2021;11:16144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dyer AH, Jones K, Dunne J, Mooney A, Gaffney F, O'Connor L, Leavy D, O'Brien K, Dowds J, Sugrue JA, Hopkins D, Martin-Loeches I, Ni Cheallaigh C, Nadarajan P, McLaughlin AM, Bourke NM, Bergin C, O'Farrelly C, Bannan C, Conlon N. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One 2020;15:e0240784.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Perez O, Merino E, Leon-Ramirez JM, Andres M, Ramos JM, Arenas-Jimenez J, Asensio S, Sanchez R, Ruiz-Torregrosa P, Galan I, Scholz A, Amo A, Gonzalez-delaAleja P, Boix V, Gil J, COVID19-ALC research group . Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J Infect 2021;82:378&#x2013;383.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Fogarty H, Dyer A, Martin-Loeches I, Bannan C, Nadarajan P, Bergin C, O'Farrelly C, Conlon N, Bourke NM, Ward SE, Byrne M, Ryan K, O'Connell N, O'Sullivan JM, Ni Cheallaigh C, O'Donnell JS. Prolonged elevation of D-dimer levels in convalescent COVID-19 patients is independent of the acute phase response. J Thromb Haemost 2021;19:1064&#x2013;1070.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8013297</ArticleId><ArticleId IdType="pubmed">33587810</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin Y, Wu J, Chen T, Li J, Zhang G, Wu D, Zhou Y, Zheng N, Cai A, Ning Q, Manyande A, Xu F, Wang J, Zhu W. Long-term microstructure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations. J Clin Invest 2021;131:e147329.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8262559</ArticleId><ArticleId IdType="pubmed">33630760</ArticleId></ArticleIdList></Reference><Reference><Citation>Paneroni M, Pasini E, Vitacca M, Scalvini S, Comini L, Pedrinolla A, Venturelli M. Altered vascular endothelium-dependent responsiveness in frail elderly patients recovering from COVID-19 pneumonia: preliminary evidence. J Clin Med 2021;10:2558.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8228458</ArticleId><ArticleId IdType="pubmed">34207876</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasini E, Corsetti G, Romano C, Scarabelli TM, Chen-Scarabelli C, Saravolatz L, Dioguardi FS. Serum metabolic profile in patients with long-COVID (PASC) syndrome: clinical implications. Front Med (Lausanne) 2021;8:714426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8339407</ArticleId><ArticleId IdType="pubmed">34368201</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmon-Ceron D, Slama D, De Broucker T, Karmochkine M, Pavie J, Sorbets E, Etienne N, Batisse D, Spiridon G, Baut VL, Meritet JF, Pichard E, Canoui-Poitrine F, APHP COVID-19 research collaboration . Clinical, virological and imaging profile in patients with prolonged forms of COVID-19: a cross-sectional study. J Infect 2021;82:e1&#x2013;e4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833274</ArticleId><ArticleId IdType="pubmed">33285216</ArticleId></ArticleIdList></Reference><Reference><Citation>Venturelli S, Benatti SV, Casati M, Binda F, Zuglian G, Imeri G, Conti C, Biffi AM, Spada MS, Bondi E, Camera G, Severgnini R, Giammarresi A, Marinaro C, Rossini A, Bonaffini PA, Guerra G, Bellasi A, Cesa S, Rizzi M. Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation. Epidemiol Infect 2021;149:e32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7873454</ArticleId><ArticleId IdType="pubmed">33461632</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Cassar MP, Tunnicliffe EM, Filippini N, Griffanti L, Alfaro-Almagro F, Okell T, Sheerin F, Xie C, Mahmod M, Mozes FE, Lewandowski AJ, Ohuma EO, Holdsworth D, Lamlum H, Woodman MJ, Krasopoulos C, Mills R, McConnell FAK, Wang C, Arthofer C, Lange FJ, Andersson J, Jenkinson M, Antoniades C, Channon KM, Shanmuganathan M, Ferreira VM, Piechnik SK, Klenerman P, Brightling C, Talbot NP, Petousi N, Rahman NM, Ho LP, Saunders K, Geddes JR, Harrison PJ, Pattinson K, Rowland MJ, Angus BJ, Gleeson F, Pavlides M, Koychev I, Miller KL, Mackay C, Jezzard P, Smith SM, Neubauer S. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine 2021;31:100683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T, Boehm A, Sahanic S, Pizzini A, Aichner M, Sonnweber B, Kurz K, Koppelstatter S, Haschka D, Petzer V, Hilbe R, Theurl M, Lehner D, Nairz M, Puchner B, Luger A, Schwabl C, Bellmann-Weiler R, Woll E, Widmann G, Tancevski I, Judith Loffler R, Weiss G. Persisting alterations of iron homeostasis in COVID-19 are associated with non-resolving lung pathologies and poor patients&#x2019; performance: a prospective observational cohort study. Respir Res 2020;21:276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7575703</ArticleId><ArticleId IdType="pubmed">33087116</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, Juno JA, Burrell LM, Kent SJ, Dore GJ, Kelleher AD, Matthews GV. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol 2022;23:210&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Doykov I, Hallqvist J, Gilmour KC, Grandjean L, Mills K, Heywood WE. The long tail of COVID-19&#x2019;&#x2014;the detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients. F1000Res 2020;9:1349.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7745182</ArticleId><ArticleId IdType="pubmed">33391730</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson BK, Guevara-Coto J, Yogendra R, Francisco EB, Long E, Pise A, Rodrigues H, Parikh P, Mora J, Mora-Rodriguez RA. Immune-based prediction of COVID-19 severity and chronicity decoded using machine learning. Front Immunol 2021;12:700782.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8273732</ArticleId><ArticleId IdType="pubmed">34262570</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H, Townsend L, Morrin H, Ahmad A, Comerford C, Karampini E, Englert H, Byrne M, Bergin C, O'Sullivan JM, Martin-Loeches I, Nadarajan P, Bannan C, Mallon PW, Curley GF, Preston RJS, Rehill AM, McGonagle D, Ni Cheallaigh C, Baker RI, Renne T, Ward SE, O'Donnell JS; Irish COVID-19 Vasculopathy Study (iCVS) investigators . Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J Thromb Haemost 2021;19:2546&#x2013;2553.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8420256</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas T, Stefanoni D, Dzieciatkowska M, Issaian A, Nemkov T, Hill RC, Francis RO, Hudson KE, Buehler PW, Zimring JC, Hod EA, Hansen KC, Spitalnik SL, D'Alessandro A. Evidence of structural protein damage and membrane lipid remodeling in red blood cells from COVID-19 patients. J Proteome Res 2020;19:4455&#x2013;4469.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7640979</ArticleId><ArticleId IdType="pubmed">33103907</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong SW, Fan BE, Huang W, Chia YW. ST-segment elevation myocardial infarction in post-COVID-19 patients: a case series. Ann Acad Med Singap 2021;50:425&#x2013;430.</Citation><ArticleIdList><ArticleId IdType="pubmed">34100519</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao YM, Shang YM, Song WB, Li QQ, Xie H, Xu QF, Jia JL, Li LM, Mao HL, Zhou XM, Luo H, Gao YF, Xu AG. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine 2020;25:100463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361108</ArticleId><ArticleId IdType="pubmed">32838236</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes E, Wist J, Masuda R, Lodge S, Nitschke P, Kimhofer T, Loo RL, Begum S, Boughton B, Yang R, Morillon AC, Chin ST, Hall D, Ryan M, Bong SH, Gay M, Edgar DW, Lindon JC, Richards T, Yeap BB, Pettersson S, Spraul M, Schaefer H, Lawler NG, Gray N, Whiley L, Nicholson JK. Incomplete systemic recovery and metabolic phenoreversion in post-acute-phase nonhospitalized COVID-19 patients: implications for assessment of post-acute COVID-19 syndrome. J Proteome Res 2021;20:3315&#x2013;3329.</Citation><ArticleIdList><ArticleId IdType="pubmed">34009992</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Mei F, Bai L, Zhou S, Liu D, Yao L, Ahluwalia A, Ghiladi RA, Su L, Shu T, Gong M, Wang X, Zhu L, Cai K, Zhang X. Serum nitrite and nitrate: a potential biomarker for post-COVID-19 complications? Free Radic Biol Med 2021;175:216&#x2013;225.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8404395</ArticleId><ArticleId IdType="pubmed">34474106</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg A, Seeliger B, Derda AA, Xiao K, Gietz A, Scherf K, Sonnenschein K, Pink I, Hoeper MM, Welte T, Bauersachs J, David S, Bar C, Thum T. Circulating cardiovascular microRNAs in critically ill COVID-19 patients. Eur J Heart Fail 2021;23:468&#x2013;475.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8014268</ArticleId><ArticleId IdType="pubmed">33421274</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Z, Wang J, Wang Z, Sun Y, Wu J, Zhang Y, Liu X, Zhou Z, Zhou L, Zhang CY, Yi Y, Xia X, Wang L, Chen X. A virus-derived microRNA-like small RNA serves as a serum biomarker to prioritize the COVID-19 patients at high risk of developing severe disease. Cell Discov 2021;7:48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8257610</ArticleId><ArticleId IdType="pubmed">34226530</ArticleId></ArticleIdList></Reference><Reference><Citation>Badimon L, Robinson EL, Jusic A, Carpusca I, deWindt LJ, Emanueli C, Ferdinandy P, Gu W, Gyongyosi M, Hackl M, Karaduzovic-Hadziabdic K, Lustrek M, Martelli F, Nham E, Potocnjak I, Satagopam V, Schneider R, Thum T, Devaux Y. Cardiovascular RNA markers and artificial intelligence may improve COVID-19 outcome: a position paper from the EU-CardioRNA COST action CA17129. Cardiovasc Res 2021;117:1823&#x2013;1840.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8083253</ArticleId><ArticleId IdType="pubmed">33839767</ArticleId></ArticleIdList></Reference><Reference><Citation>Hachim MY, Al Heialy S, Senok A, Hamid Q, Alsheikh-Ali A. Molecular basis of cardiac and vascular injuries associated with COVID-19. Front Cardiovasc Med 2020;7:582399.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7669624</ArticleId><ArticleId IdType="pubmed">33240937</ArticleId></ArticleIdList></Reference><Reference><Citation>Files JK, Sarkar S, Fram TR, Boppana S, Sterrett S, Qin K, Bansal A, Long DM, Sabbaj S, Kobie JJ, Goepfert PA, Erdmann N. Duration of post-COVID-19 symptoms is associated with sustained SARS-CoV-2-specific immune responses. JCI Insight 2021;6:e151544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8410022</ArticleId><ArticleId IdType="pubmed">34143754</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao L, Wang GL, Shen Y, Wang ZY, Zhan BD, Duan LJ, Lu B, Shi C, Gao YM, Peng HH, Wang GQ, Wang DM, Jiang MD, Cao GP, Ma MJ. Persistence of antibody and cellular immune responses in coronavirus disease 2019 patients over nine months after infection. J Infect Dis 2021;224:586&#x2013;594.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8243600</ArticleId><ArticleId IdType="pubmed">33978754</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang SE, Feng A, Meng W, Apostolidis SA, Mack E, Artandi M, Barman L, Bennett K, Chakraborty S, Chang I, Cheung P, Chinthrajah S, Dhingra S, Do E, Finck A, Gaano A, Gessner R, Giannini HM, Gonzalez J, Greib S, Gundisch M, Hsu AR, Kuo A, Manohar M, Mao R, Neeli I, Neubauer A, Oniyide O, Powell AE, Puri R, Renz H, Schapiro J, Weidenbacher PA, Wittman R, Ahuja N, Chung HR, Jagannathan P, James JA, Kim PS, Meyer NJ, Nadeau KC, Radic M, Robinson WH, Singh U, Wang TT, Wherry EJ, Skevaki C, Luning Prak ET, Utz PJ. New-onset IgG autoantibodies in hospitalized patients with COVID-19. Nat Commun 2021;12:5417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8440763</ArticleId><ArticleId IdType="pubmed">34521836</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter AG, Shields AM, Karim A, Birch D, Faustini SE, Steadman L, Ward K, Plant T, Reynolds G, Veenith T, Cunningham AF, Drayson MT, Wraith DC. Establishing the prevalence of common tissue-specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection. Clin Exp Immunol 2021;205:99&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8239842</ArticleId><ArticleId IdType="pubmed">34082475</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultheiss HP, Baumeier C, Pietsch H, Bock CT, Poller W, Escher F. Cardiovascular consequences of viral infections: from COVID to other viral diseases. Cardiovasc Res 2021;117:2610&#x2013;2623.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8500164</ArticleId><ArticleId IdType="pubmed">34609508</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawadogo SA, Dighero-Kemp B, Ouedraogo DD, Hensley L, Sakande J. How NETosis could drive &#x201c;post-COVID-19 syndrome&#x201d; among survivors. Immunol Lett 2020;228:35&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7524448</ArticleId><ArticleId IdType="pubmed">33007368</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng H, Havervall S, Rosell A, Aguilera K, Parv K, von Meijenfeldt FA, Lisman T, Mackman N, Thalin C, Phillipson M. Circulating markers of neutrophil extracellular traps are of prognostic value in patients with COVID-19. Arterioscler Thromb Vasc Biol 2021;41:988&#x2013;994.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7837697</ArticleId><ArticleId IdType="pubmed">33267662</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin LB, Weinstock LB, Molderings GJ. COVID-19 hyperinflammation and post-COVID-19 illness may be rooted in mast cell activation syndrome. Int J Infect Dis 2020;100:327&#x2013;332.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7529115</ArticleId><ArticleId IdType="pubmed">32920235</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubankova M, Hohberger B, Hoffmanns J, Furst J, Herrmann M, Guck J, Krater M. Physical phenotype of blood cells is altered in COVID-19. Biophys J 2021;120:2838&#x2013;2847.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8169220</ArticleId><ArticleId IdType="pubmed">34087216</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood E, Hall KH, Tate W. Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: a possible approach to SARS-CoV-2 &#x2018;long-haulers&#x2019;? Chronic Dis Transl Med 2021;7:14&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7680046</ArticleId><ArticleId IdType="pubmed">33251031</ArticleId></ArticleIdList></Reference><Reference><Citation>De Biasi S, Meschiari M, Gibellini L, Bellinazzi C, Borella R, Fidanza L, Gozzi L, Iannone A, Lo Tartaro D, Mattioli M, Paolini A, Menozzi M, Milic J, Franceschi G, Fantini R, Tonelli R, Sita M, Sarti M, Trenti T, Brugioni L, Cicchetti L, Facchinetti F, Pietrangelo A, Clini E, Girardis M, Guaraldi G, Mussini C, Cossarizza A. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat Commun 2020;11:3434.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7338513</ArticleId><ArticleId IdType="pubmed">32632085</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme J, Borghesan M, Mackedenski S, Bird TG, Demaria M. Cellular senescence as a potential mediator of COVID-19 severity in the elderly. Aging Cell 2020;19:e13237.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7576296</ArticleId><ArticleId IdType="pubmed">32955770</ArticleId></ArticleIdList></Reference><Reference><Citation>Blagosklonny MV. From causes of aging to death from COVID-19. Aging (Albany NY) 2020;12:10004&#x2013;10021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7346074</ArticleId><ArticleId IdType="pubmed">32534452</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohn A, Weber D, Jung T, Ott C, Hugo M, Kochlik B, Kehm R, Konig J, Grune T, Castro JP. Happily (n)ever after: aging in the context of oxidative stress, proteostasis loss and cellular senescence. Redox Biol 2017;11:482&#x2013;501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5228102</ArticleId><ArticleId IdType="pubmed">28086196</ArticleId></ArticleIdList></Reference><Reference><Citation>Froidure A, Mahieu M, Hoton D, Laterre PF, Yombi JC, Koenig S, Ghaye B, Defour JP, Decottignies A. Short telomeres increase the risk of severe COVID-19. Aging (Albany NY) 2020;12:19911&#x2013;19922.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7655194</ArticleId><ArticleId IdType="pubmed">33104521</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Vazquez R, Guio-Carrion A, Zapatero-Gaviria A, Martinez P, Blasco MA. Shorter telomere lengths in patients with severe COVID-19 disease. Aging (Albany NY) 2021;13:1&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7835063</ArticleId><ArticleId IdType="pubmed">33428591</ArticleId></ArticleIdList></Reference><Reference><Citation>Horvath S, Raj K. DNA methylation-based biomarkers and the epigenetic clock theory of ageing. Nat Rev Genet 2018;19:371&#x2013;384.</Citation><ArticleIdList><ArticleId IdType="pubmed">29643443</ArticleId></ArticleIdList></Reference><Reference><Citation>Mongelli A, Barbi V, Gottardi Zamperla M, Atlante S, Forleo L, Nesta M, Massetti M, Pontecorvi A, Nanni S, Farsetti A, Catalano O, Bussotti M, Dalla Vecchia LA, Bachetti T, Martelli F, La Rovere MT, Gaetano C. Evidence for biological age acceleration and telomere shortening in COVID-19 survivors. Int J Mol Sci 2021;22:6151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8201243</ArticleId><ArticleId IdType="pubmed">34200325</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh M, Bansal V, Feschotte C. A single-cell RNA expression map of human coronavirus entry factors. Cell Rep 2020;32:108175.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7470764</ArticleId><ArticleId IdType="pubmed">32946807</ArticleId></ArticleIdList></Reference><Reference><Citation>Duarte C, Akkaoui J, Ho A, Garcia C, Yamada C, Movila A. Age-dependent effects of the recombinant spike protein/SARS-CoV-2 on the M-CSF- and IL-34-differentiated macrophages in vitro. Biochem Biophys Res Commun 2021;546:97&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857081</ArticleId><ArticleId IdType="pubmed">33578295</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer K, Patra T, Vijayamahantesh M, Ray R. SARS-CoV-2 spike protein induces paracrine senescence and leukocyte adhesion in endothelial cells. J Virol 2021; 95:e0079421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8354225</ArticleId><ArticleId IdType="pubmed">34160250</ArticleId></ArticleIdList></Reference><Reference><Citation>Amendola A, Garoffolo G, Songia P, Nardacci R, Ferrari S, Bernava G, Canzano P, Myasoedova V, Colavita F, Castilletti C, Sberna G, Capobianchi MR, Piacentini M, Agrifoglio M, Colombo GI, Poggio P, Pesce M. Human cardiosphere-derived stromal cells exposed to SARS-CoV-2 evolve into hyper-inflammatory/pro-fibrotic phenotype and produce infective viral particles depending on the levels of ACE2 receptor expression. Cardiovasc Res 2021;117:1557&#x2013;1566.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7989620</ArticleId><ArticleId IdType="pubmed">33705542</ArticleId></ArticleIdList></Reference><Reference><Citation>Camell CD, Yousefzadeh MJ, Zhu Y, Prata L, Huggins MA, Pierson M, Zhang L, O'Kelly RD, Pirtskhalava T, Xun P, Ejima K, Xue A, Tripathi U, Espindola-Netto JM, Giorgadze N, Atkinson EJ, Inman CL, Johnson KO, Cholensky SH, Carlson TW, LeBrasseur NK, Khosla S, O'Sullivan MG, Allison DB, Jameson SC, Meves A, Li M, Prakash YS, Chiarella SE, Hamilton SE, Tchkonia T, Niedernhofer LJ, Kirkland JL, Robbins PD. Senolytics reduce coronavirus-related mortality in old mice. Science 2021;373:eabe4832.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8607935</ArticleId><ArticleId IdType="pubmed">34103349</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Yu Y, Trimpert J, Benthani F, Mairhofer M, Richter-Pechanska P, Wyler E, Belenki D, Kaltenbrunner S, Pammer M, Kausche L, Firsching TC, Dietert K, Schotsaert M, Martinez-Romero C, Singh G, Kunz S, Niemeyer D, Ghanem R, Salzer HJF, Paar C, Mulleder M, Uccellini M, Michaelis EG, Khan A, Lau A, Schonlein M, Habringer A, Tomasits J, Adler JM, Kimeswenger S, Gruber AD, Hoetzenecker W, Steinkellner H, Purfurst B, Motz R, Di Pierro F, Lamprecht B, Osterrieder N, Landthaler M, Drosten C, Garcia-Sastre A, Langer R, Ralser M, Eils R, Reimann M, Fan DNY, Schmitt CA. Virus-induced senescence is a driver and therapeutic target in COVID-19. Nature 2021;599:283&#x2013;289.</Citation><ArticleIdList><ArticleId IdType="pubmed">34517409</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindner D, Fitzek A, Brauninger H, Aleshcheva G, Edler C, Meissner K, Scherschel K, Kirchhof P, Escher F, Schultheiss HP, Blankenberg S, Puschel K, Westermann D. Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases. JAMA Cardiol 2020;5:1281&#x2013;1285.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385672</ArticleId><ArticleId IdType="pubmed">32730555</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan A, Zlitni S, Brooks EF, Vance SE, Dahlen A, Hedlin H, Park RM, Han A, Schmidtke DT, Verma R, Jacobson KB, Parsonnet J, Bonilla HF, Singh U, Pinsky BA, Andrews JR, Jagannathan P, Bhatt AS. Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Med (N Y) 2022;3:371&#x2013;387.e9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9005383</ArticleId><ArticleId IdType="pubmed">35434682</ArticleId></ArticleIdList></Reference><Reference><Citation>Zollner A, Koch R, Jukic A, Pfister A, Meyer M, Rossler A, Kimpel J, Adolph TE, Tilg H. Post-acute COVID-19 is characterized by gut viral antigen persistence in inflammatory bowel diseases. Gastroenterology 2022;163:495&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9057012</ArticleId><ArticleId IdType="pubmed">35508284</ArticleId></ArticleIdList></Reference><Reference><Citation>Roe K. A role for T-cell exhaustion in long COVID-19 and severe outcomes for several categories of COVID-19 patients. J Neurosci Res 2021;99:2367&#x2013;2376.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8427009</ArticleId><ArticleId IdType="pubmed">34288064</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng MH, Zhang S, Porritt RA, Noval Rivas M, Paschold L, Willscher E, Binder M, Arditi M, Bahar I. Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation. Proc Natl Acad Sci U S A 2020;117:25254&#x2013;25262.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7568239</ArticleId><ArticleId IdType="pubmed">32989130</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, Li S, Hong S, Zhang R, Xie J, Kornilov SA, Scherler K, Pavlovitch-Bedzyk AJ, Dong S, Lausted C, Lee I, Fallen S, Dai CL, Baloni P, Smith B, Duvvuri VR, Anderson KG, Li J, Yang F, Duncombe CJ, McCulloch DJ, Rostomily C, Troisch P, Zhou J, Mackay S, DeGottardi Q, May DH, Taniguchi R, Gittelman RM, Klinger M, Snyder TM, Roper R, Wojciechowska G, Murray K, Edmark R, Evans S, Jones L, Zhou Y, Rowen L, Liu R, Chour W, Algren HA, Berrington WR, Wallick JA, Cochran RA, Micikas ME, Wrin T, Petropoulos CJ, Cole HR, Fischer TD, Wei W, Hoon DSB, Price ND, Subramanian N, Hill JA, Hadlock J, Magis AT, Ribas A, Lanier LL, Boyd SD, Bluestone JA, Chu H, Hood L, Gottardo R, Greenberg PD, Davis MM, Goldman JD, Heath JR. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell 2022;185:881&#x2013;895.e820.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Pesce M, Agostoni P, Botker HE, Brundel B, Davidson SM, Caterina R, Ferdinandy P, Girao H, Gyongyosi M, Hulot JS, Lecour S, Perrino C, Schulz R, Sluijter JP, Steffens S, Tancevski I, Gollmann-Tepekoylu C, Tschope C, Linthout SV, Madonna R. COVID-19-related cardiac complications from clinical evidences to basic mechanisms: opinion paper of the ESC working group on cellular biology of the heart. Cardiovasc Res 2021;117:2148&#x2013;2160.</Citation><ArticleIdList><ArticleId IdType="pubmed">34117887</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey AL, Dmytrenko O, Greenberg L, Bredemeyer AL, Ma P, Liu J, Penna V, Winkler ES, Sviben S, Brooks E, Nair AP, Heck KA, Rali AS, Simpson L, Saririan M, Hobohm D, Stump WT, Fitzpatrick JA, Xie X, Zhang X, Shi PY, Hinson JT, Gi WT, Schmidt C, Leuschner F, Lin CY, Diamond MS, Greenberg MJ, Lavine KJ. SARS-CoV-2 infects human engineered heart tissues and models COVID-19 myocarditis. JACC Basic Transl Sci 2021;6:331&#x2013;345.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7909907</ArticleId><ArticleId IdType="pubmed">33681537</ArticleId></ArticleIdList></Reference><Reference><Citation>Bojkova D, Wagner JUG, Shumliakivska M, Aslan GS, Saleem U, Hansen A, Luxan G, Gunther S, Pham MD, Krishnan J, Harter PN, Ermel UH, Frangakis AS, Milting H, Zeiher AM, Klingel K, Cinatl J, Dendorfer A, Eschenhagen T, Tschope C, Ciesek S, Dimmeler S. SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes. Cardiovasc Res 2020;116:2207&#x2013;2215.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7543363</ArticleId><ArticleId IdType="pubmed">32966582</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard I, Limonta D, Mahal LK, Hobman TC. Endothelium infection and dysregulation by SARS-CoV-2: evidence and caveats in COVID-19. Viruses 2020;13:29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7823949</ArticleId><ArticleId IdType="pubmed">33375371</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanacli R, Doeblin P, Gotze C, Zieschang V, Faragli A, Stehning C, Korosoglou G, Erley J, Weiss J, Berger A, Propper F, Steinbeis F, Kuhne T, Seidel F, Geisel D, Cannon Walter-Rittel T, Stawowy P, Witzenrath M, Klingel K, Van Linthout S, Pieske B, Tschope C, Kelle S. COVID-19 vs. classical myocarditis associated myocardial injury evaluated by cardiac magnetic resonance and endomyocardial biopsy. Front Cardiovasc Med 2021;8:737257.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8739473</ArticleId><ArticleId IdType="pubmed">35004872</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant RA, Morales-Nebreda L, Markov NS, Swaminathan S, Querrey M, Guzman ER, Abbott DA, Donnelly HK, Donayre A, Goldberg IA, Klug ZM, Borkowski N, Lu Z, Kihshen H, Politanska Y, Sichizya L, Kang M, Shilatifard A, Qi C, Lomasney JW, Argento AC, Kruser JM, Malsin ES, Pickens CO, Smith SB, Walter JM, Pawlowski AE, Schneider D, Nannapaneni P, Abdala-Valencia H, Bharat A, Gottardi CJ, Budinger GRS, Misharin AV, Singer BD, Wunderink RG. Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia. Nature 2021;590:635&#x2013;641.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7987233</ArticleId><ArticleId IdType="pubmed">33429418</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox SE, Falgout L, Vander Heide RS. COVID-19 myocarditis: quantitative analysis of the inflammatory infiltrate and a proposed mechanism. Cardiovasc Pathol 2021;54:107361.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8223028</ArticleId><ArticleId IdType="pubmed">34174415</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans PC, Rainger GE, Mason JC, Guzik TJ, Osto E, Stamataki Z, Neil D, Hoefer IE, Fragiadaki M, Waltenberger J, Weber C, Bochaton-Piallat ML, Back M. Endothelial dysfunction in COVID-19: a position paper of the ESC working group for atherosclerosis and vascular biology, and the ESC council of basic cardiovascular science. Cardiovasc Res 2020;116:2177&#x2013;2184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454368</ArticleId><ArticleId IdType="pubmed">32750108</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro P, Palomo M, Moreno-Castano AB, Fernandez S, Torramade-Moix S, Pascual G, Martinez-Sanchez J, Richardson E, Tellez A, Nicolas JM, Carreras E, Richardson PG, Badimon JJ, Escolar G, Diaz-Ricart M. Is the endothelium the missing link in the pathophysiology and treatment of COVID-19 complications? Cardiovasc Drugs Ther 2021;36:547&#x2013;560.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8181544</ArticleId><ArticleId IdType="pubmed">34097193</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambadiari V, Mitrakou A, Kountouri A, Thymis J, Katogiannis K, Korakas E, Varlamos C, Andreadou I, Tsoumani M, Triantafyllidi H, Bamias A, Thomas K, Kazakou P, Grigoropoulou S, Kavatha D, Antoniadou A, Dimopoulos MA, Ikonomidis I. Association of COVID-19 with impaired endothelial glycocalyx, vascular function and myocardial deformation 4 months after infection. Eur J Heart Fail 2021;23:1916&#x2013;1926.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8426810</ArticleId><ArticleId IdType="pubmed">34415085</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostergaard L. SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: consequences of capillary transit-time changes, tissue hypoxia and inflammation. Physiol Rep 2021;9:e14726.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7849453</ArticleId><ArticleId IdType="pubmed">33523608</ArticleId></ArticleIdList></Reference><Reference><Citation>Bienvenu LA, Noonan J, Wang X, Peter K. Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities. Cardiovasc Res 2020;116:2197&#x2013;2206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665363</ArticleId><ArticleId IdType="pubmed">33063089</ArticleId></ArticleIdList></Reference><Reference><Citation>Bucciarelli V, Nasi M, Bianco F, Seferovic J, Ivkovic V, Gallina S, Mattioli AV. Depression pandemic and cardiovascular risk in the COVID-19 era and long COVID syndrome: gender makes a difference. Trends Cardiovasc Med 2022;32:12&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8490128</ArticleId><ArticleId IdType="pubmed">34619336</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q. Human genetics of life-threatening influenza pneumonitis. Hum Genet 2020;139:941&#x2013;948.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7094886</ArticleId><ArticleId IdType="pubmed">32025908</ArticleId></ArticleIdList></Reference><Reference><Citation>Guler A A, Tombul N, Aysert Yildiz P, Ozger HS, Hizel K, Gulbahar O, Tufan A, Erbas G, Aygencel G, Guzel Tunccan O, Dizbay M, Ozturk MA. The assessment of serum ACE activity in COVID-19 and its association with clinical features and severity of the disease. Scand J Clin Lab Invest 2021;81:160&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832453</ArticleId><ArticleId IdType="pubmed">33474994</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Bastard P, Liu Z, Le Pen J, Moncada-Velez M, Chen J, Ogishi M, Sabli IKD, Hodeib S, Korol C, Rosain J, Bilguvar K, Ye J, Bolze A, Bigio B, Yang R, Arias AA, Zhou Q, Zhang Y, Onodi F, Korniotis S, Karpf L, Philippot Q, Chbihi M, Bonnet-Madin L, Dorgham K, Smith N, Schneider WM, Razooky BS, Hoffmann HH, Michailidis E, Moens L, Han JE, Lorenzo L, Bizien L, Meade P, Neehus AL, Ugurbil AC, Corneau A, Kerner G, Zhang P, Rapaport F, Seeleuthner Y, Manry J, Masson C, Schmitt Y, Schluter A, Le Voyer T, Khan T, Li J, Fellay J, Roussel L, Shahrooei M, Alosaimi MF, Mansouri D, Al-Saud H, Al-Mulla F, Almourfi F, Al-Muhsen SZ, Alsohime F, Al Turki S, Hasanato R, van de Beek D, Biondi A, Bettini LR, D'Angio M, Bonfanti P, Imberti L, Sottini A, Paghera S, Quiros-Roldan E, Rossi C, Oler AJ, Tompkins MF, Alba C, Vandernoot I, Goffard JC, Smits G, Migeotte I, Haerynck F, Soler-Palacin P, Martin-Nalda A, Colobran R, Morange PE, Keles S, Colkesen F, Ozcelik T, Yasar KK, Senoglu S, Karabela SN, Rodriguez-Gallego C, Novelli G, Hraiech S, Tandjaoui-Lambiotte Y, Duval X, Laouenan C, Clinicians C-S, Clinicians C, Imagine CG, French CCSG, Co VCC, Amsterdam UMCC-B, Effort CHG, Group N-UTCI, Snow AL, Dalgard CL, Milner JD, Vinh DC, Mogensen TH, Marr N, Spaan AN, Boisson B, Boisson-Dupuis S, Bustamante J, Puel A, Ciancanelli MJ, Meyts I, Maniatis T, Soumelis V, Amara A, Nussenzweig M, Garcia-Sastre A, Krammer F, Pujol A, Duffy D, Lifton RP, Zhang SY, Gorochov G, Beziat V, Jouanguy E, Sancho-Shimizu V, Rice CM, Abel L, Notarangelo LD, Cobat A, Su HC, Casanova JL. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science 2020;370:eabd4570.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857407</ArticleId><ArticleId IdType="pubmed">32972995</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann HH, Zhang Y, Dorgham K, Philippot Q, Rosain J, Beziat V, Manry J, Shaw E, Haljasmagi L, Peterson P, Lorenzo L, Bizien L, Trouillet-Assant S, Dobbs K, de Jesus AA, Belot A, Kallaste A, Catherinot E, Tandjaoui-Lambiotte Y, Le Pen J, Kerner G, Bigio B, Seeleuthner Y, Yang R, Bolze A, Spaan AN, Delmonte OM, Abers MS, Aiuti A, Casari G, Lampasona V, Piemonti L, Ciceri F, Bilguvar K, Lifton RP, Vasse M, Smadja DM, Migaud M, Hadjadj J, Terrier B, Duffy D, Quintana-Murci L, van de Beek D, Roussel L, Vinh DC, Tangye SG, Haerynck F, Dalmau D, Martinez-Picado J, Brodin P, Nussenzweig MC, Boisson-Dupuis S, Rodriguez-Gallego C, Vogt G, Mogensen TH, Oler AJ, Gu J, Burbelo PD, Cohen JI, Biondi A, Bettini LR, D'Angio M, Bonfanti P, Rossignol P, Mayaux J, Rieux-Laucat F, Husebye ES, Fusco F, Ursini MV, Imberti L, Sottini A, Paghera S, Quiros-Roldan E, Rossi C, Castagnoli R, Montagna D, Licari A, Marseglia GL, Duval X, Ghosn J, Lab H, Clinicians C, Clinicians C-S, Imagine CG, French CCSG, Milieu Interieur C, Co VCC, Amsterdam UMCC-B, Effort CHG, Tsang JS, Goldbach-Mansky R, Kisand K, Lionakis MS, Puel A, Zhang SY, Holland SM, Gorochov G, Jouanguy E, Rice CM, Cobat A, Notarangelo LD, Abel L, Su HC, Casanova JL. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science 2020;370:eabd4585.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, Cook JR, Nordvig AS, Shalev D, Sehrawat TS, Ahluwalia N, Bikdeli B, Dietz D, Der-Nigoghossian C, Liyanage-Don N, Rosner GF, Bernstein EJ, Mohan S, Beckley AA, Seres DS, Choueiri TK, Uriel N, Ausiello JC, Accili D, Freedberg DE, Baldwin M, Schwartz A, Brodie D, Garcia CK, Elkind MSV, Connors JM, Bilezikian JP, Landry DW, Wan EY. Post-acute COVID-19 syndrome. Nat Med 2021;27:601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva RP, Goncalves JIB, Zanin RF, Schuch FB, de Souza APD. Circulating type I interferon levels and COVID-19 severity: a systematic review and meta-analysis. Front Immunol 2021;12:657363.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8149905</ArticleId><ArticleId IdType="pubmed">34054820</ArticleId></ArticleIdList></Reference><Reference><Citation>Covid GG S, Ellinghaus D, Degenhardt F, Bujanda L, Buti M, Albillos A, Invernizzi P, Fernandez J, Prati D, Baselli G, Asselta R, Grimsrud MM, Milani C, Aziz F, Kassens J, May S, Wendorff M, Wienbrandt L, Uellendahl-Werth F, Zheng T, Yi X, de Pablo R, Chercoles AG, Palom A, Garcia-Fernandez AE, Rodriguez-Frias F, Zanella A, Bandera A, Protti A, Aghemo A, Lleo A, Biondi A, Caballero-Garralda A, Gori A, Tanck A, Carreras Nolla A, Latiano A, Fracanzani AL, Peschuck A, Julia A, Pesenti A, Voza A, Jimenez D, Mateos B, Nafria Jimenez B, Quereda C, Paccapelo C, Gassner C, Angelini C, Cea C, Solier A, Pestana D, Muniz-Diaz E, Sandoval E, Paraboschi EM, Navas E, Garcia Sanchez F, Ceriotti F, Martinelli-Boneschi F, Peyvandi F, Blasi F, Tellez L, Blanco-Grau A, Hemmrich-Stanisak G, Grasselli G, Costantino G, Cardamone G, Foti G, Aneli S, Kurihara H, ElAbd H, My I, Galvan-Femenia I, Martin J, Erdmann J, Ferrusquia-Acosta J, Garcia-Etxebarria K, Izquierdo-Sanchez L, Bettini LR, Sumoy L, Terranova L, Moreira L, Santoro L, Scudeller L, Mesonero F, Roade L, Ruhlemann MC, Schaefer M, Carrabba M, Riveiro-Barciela M, Figuera Basso ME, Valsecchi MG, Hernandez-Tejero M, Acosta-Herrera M, D'Angio M, Baldini M, Cazzaniga M, Schulzky M, Cecconi M, Wittig M, Ciccarelli M, Rodriguez-Gandia M, Bocciolone M, Miozzo M, Montano N, Braun N, Sacchi N, Martinez N, Ozer O, Palmieri O, Faverio P, Preatoni P, Bonfanti P, Omodei P, Tentorio P, Castro P, Rodrigues PM, Blandino Ortiz A, de Cid R, Ferrer R, Gualtierotti R, Nieto R, Goerg S, Badalamenti S, Marsal S, Matullo G, Pelusi S, Juzenas S, Aliberti S, Monzani V, Moreno V, Wesse T, Lenz TL, Pumarola T, Rimoldi V, Bosari S, Albrecht W, Peter W, Romero-Gomez M, D'Amato M, Duga S, Banales JM, Hov JR, Folseraas T, Valenti L, Franke A, Karlsen TH. Genomewide association study of severe COVID-19 with respiratory failure. N Engl J Med 2020;383:1522&#x2013;1534.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7315890</ArticleId><ArticleId IdType="pubmed">32558485</ArticleId></ArticleIdList></Reference><Reference><Citation>Groot HE, Villegas Sierra LE, Said MA, Lipsic E, Karper JC, van der Harst P. Genetically determined ABO blood group and its associations with health and disease. Arterioscler Thromb Vasc Biol 2020;40:830&#x2013;838.</Citation><ArticleIdList><ArticleId IdType="pubmed">31969017</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q, Zhou L, Sun X, Yan Z, Hu C, Wu J, Xu L, Li X, Liu H, Yin P, Li K, Zhao J, Li Y, Wang X, Li Y, Zhang Q, Xu G, Chen H. Altered lipid metabolism in recovered SARS patients twelve years after infection. Sci Rep 2017;7:9110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5567209</ArticleId><ArticleId IdType="pubmed">28831119</ArticleId></ArticleIdList></Reference><Reference><Citation>Abegaz SB. Human ABO blood groups and their associations with different diseases. BioMed Res Int 2021;2021:6629060.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850852</ArticleId><ArticleId IdType="pubmed">33564677</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID Human Genetic Effort.</Citation></Reference><Reference><Citation>Marx V. Scientists set out to connect the dots on long COVID. Nat Methods 2021;18:449&#x2013;453.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8081406</ArticleId><ArticleId IdType="pubmed">33911230</ArticleId></ArticleIdList></Reference><Reference><Citation>Pairo-Castineira E, Clohisey S, Klaric L, Bretherick AD, Rawlik K, Pasko D, Walker S, Parkinson N, Fourman MH, Russell CD, Furniss J, Richmond A, Gountouna E, Wrobel N, Harrison D, Wang B, Wu Y, Meynert A, Griffiths F, Oosthuyzen W, Kousathanas A, Moutsianas L, Yang Z, Zhai R, Zheng C, Grimes G, Beale R, Millar J, Shih B, Keating S, Zechner M, Haley C, Porteous DJ, Hayward C, Yang J, Knight J, Summers C, Shankar-Hari M, Klenerman P, Turtle L, Ho A, Moore SC, Hinds C, Horby P, Nichol A, Maslove D, Ling L, McAuley D, Montgomery H, Walsh T, Pereira AC, Renieri A, Gen OI, Gen CI, Shen X, Ponting CP, Fawkes A, Tenesa A, Caulfield M, Scott R, Rowan K, Murphy L, Openshaw PJM, Semple MG, Law A, Vitart V, Wilson JF, Baillie JK. Genetic mechanisms of critical illness in COVID-19. Nature 2021;591:92&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">33307546</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Host Genetics Initiative . Mapping the human genetic architecture of COVID-19. Nature 2021;600:472&#x2013;477.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8674144</ArticleId><ArticleId IdType="pubmed">34237774</ArticleId></ArticleIdList></Reference><Reference><Citation>Downes DJ, Cross AR, Hua P, Roberts N, Schwessinger R, Cutler AJ, Munis AM, Brown J, Mielczarek O, de Andrea CE, Melero I, Gill DR, Hyde SC, Knight JC, Todd JA, Sansom SN, Issa F, Davies JOJ, Hughes JR. Identification of LZTFL1 as a candidate effector gene at a COVID-19 risk locus. Nat Genet 2021;53:1606&#x2013;1615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611960</ArticleId><ArticleId IdType="pubmed">34737427</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleary SJ, Pitchford SC, Amison RT, Carrington R, Robaina Cabrera CL, Magnen M, Looney MR, Gray E, Page CP. Animal models of mechanisms of SARS-CoV-2 infection and COVID-19 pathology. Br J Pharmacol 2020;177:4851&#x2013;4865.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7283621</ArticleId><ArticleId IdType="pubmed">32462701</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinnon KH, Leist SR, Okuda K, Dang H, Fritch EJ, Gully KL, De la Cruz G, Evangelista MD, Asakura T, Gilmore RC, Hawkins P, Nakano S, West A, Schafer A, Gralinski LE, Everman JL, Sajuthi SP, Zweigart MR, Dong S, McBride J, Cooley MR, Hines JB, Love MK, Groshong SD, VanSchoiack A, Phelan SJ, Liang Y, Hether T, Leon M, Zumwalt RE, Barton LM, Duval EJ, Mukhopadhyay S, Stroberg E, Borczuk A, Thorne LB, Sakthivel MK, Lee YZ, Hagood JS, Mock JR, Seibold MA, O'Neal WK, Montgomery SA, Boucher RC, Baric RS. A model of persistent post SARS-CoV-2 induced lung disease for target identification and testing of therapeutic strategies. bioRxiv 2022. doi.10.1101/2022.02.15.480515</Citation></Reference><Reference><Citation>Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, Wang H, Wan J, Wang X, Lu Z. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020;5:811&#x2013;818.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7101506</ArticleId><ArticleId IdType="pubmed">32219356</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu H, Ma F, Wei X, Fang Y. Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin. Eur Heart J 2021;42:206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7184348</ArticleId><ArticleId IdType="pubmed">32176300</ArticleId></ArticleIdList></Reference><Reference><Citation>Kini A, Cao D, Nardin M, Sartori S, Zhang Z, Pivato CA, Chiarito M, Nicolas J, Vengrenyuk Y, Krishnamoorthy P, Sharma SK, Dangas G, Fuster V, Mehran R. Types of myocardial injury and mid-term outcomes in patients with COVID-19. Eur Heart J Qual Care Clin Outcomes 2021;7:438&#x2013;446.</Citation><ArticleIdList><ArticleId IdType="pubmed">34458912</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollbracht C, Kraft K. Feasibility of vitamin C in the treatment of post viral fatigue with focus on long COVID, based on a systematic review of IV vitamin C on fatigue. Nutrients 2021;13:1154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8066596</ArticleId><ArticleId IdType="pubmed">33807280</ArticleId></ArticleIdList></Reference><Reference><Citation>Schomburg L. Selenium deficiency due to diet, pregnancy, severe illness, or COVID-19 &#x2013; a preventable trigger for autoimmune disease. Int J Mol Sci 2021;22:8532.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8395178</ArticleId><ArticleId IdType="pubmed">34445238</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhaiyat AM, Sasson E, Wang Z, Khairy S, Ginzarly M, Qureshi U, Fikree M, Efrati S. Hyperbaric oxygen treatment for long coronavirus disease-19: a case report. J Med Case Rep 2022;16:80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8848789</ArticleId><ArticleId IdType="pubmed">35168680</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbins T, Gonevski M, Clark C, Baitule S, Sharma K, Magar A, Patel K, Sankar S, Kyrou I, Ali A, Randeva HS. Hyperbaric oxygen therapy for the treatment of long COVID: early evaluation of a highly promising intervention. Clin Med (Lond) 2021;21:e629&#x2013;e632.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8806311</ArticleId><ArticleId IdType="pubmed">34862223</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisshoff H, Krylova O, Nikolenko H, Dungen HD, Dallmann A, Becker S, Gottel P, Muller J, Haberland A. Aptamer BC 007&#x2014;efficient binder of spreading-crucial SARS-CoV-2 proteins. Heliyon 2020;6:e05421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7605794</ArticleId><ArticleId IdType="pubmed">33163683</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimeno-Almazan A, Pallares JG, Buendia-Romero A, Martinez-Cava A, Franco-Lopez F, Sanchez-Alcaraz Martinez BJ, Bernal-Morel E, Courel-Ibanez J. Post-COVID-19 syndrome and the potential benefits of exercise. Int J Environ Res Public Health 2021;18:5329.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8156194</ArticleId><ArticleId IdType="pubmed">34067776</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheiber B, Spiegl C, Wiederin C, Schifferegger E, Schiefermeier-Mach N. Post-COVID-19 rehabilitation: perception and experience of Austrian physiotherapists and physiotherapy students. Int J Environ Res Public Health 2021;18:8730.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8394152</ArticleId><ArticleId IdType="pubmed">34444477</ArticleId></ArticleIdList></Reference><Reference><Citation>Benzarti W, Toulgui E, Prefaut C, Chamari K, Ben Saad H. General practitioners should provide the cardiorespiratory rehabilitation&#x2019; &#x2018;minimum advice&#x2019; for long COVID-19 patients. Libyan J Med 2022;17:2009101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8635671</ArticleId><ArticleId IdType="pubmed">34839808</ArticleId></ArticleIdList></Reference><Reference><Citation>Calabrese M, Garofano M, Palumbo R, Di Pietro P, Izzo C, Damato A, Venturini E, Iesu S, Virtuoso N, Strianese A, Ciccarelli M, Galasso G, Vecchione C. Exercise training and cardiac rehabilitation in COVID-19 patients with cardiovascular complications: state of art. Life (Basel) 2021;11:259.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8004041</ArticleId><ArticleId IdType="pubmed">33801080</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Bosworth M, King S. Self-reported long COVID after two doses of a coronavirus (COVID-19) vaccine in the UK: 26 January 2022. 2022.</Citation></Reference><Reference><Citation>Kuodi P, Gorelik Y, Zayyad H, Wertheim O, Wiegler KB, Jabal KA, Dror AA, Nazzal S, Glikman D, Edelstein M. Association between vaccination status and reported incidence of post-acute COVID-19 symptoms in Israel: a cross-sectional study of patients tested between march 2020 and November 2021. medRxiv 2022. doi:10.1101/2022.01.05.22268800</Citation></Reference><Reference><Citation>Arnold DT, Milne A, Samms E, Stadon L, Maskell NA, Hamilton FW. Symptoms after COVID-19 vaccination in patients with persistent symptoms after acute infection: a case series. Ann Intern Med 2021;174:1334&#x2013;1336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8252827</ArticleId><ArticleId IdType="pubmed">34029484</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis 2022;22:e102&#x2013;e107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Network TCHA . Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19). 2020.</Citation></Reference><Reference><Citation>WHO . Multisystem inflammatory syndrome in children and adolescents with COVID-19.</Citation></Reference><Reference><Citation>Ram-Mohan N, Kim D, Rogers AJ, Blish CA, Nadeau KC, Blomkalns AL, Yang S. Association between SARS-CoV-2 RNAemia and postacute sequelae of COVID-19. Open Forum Infect Dis 2022;9:ofab646.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8802799</ArticleId><ArticleId IdType="pubmed">35111870</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold DT, Hamilton FW, Milne A, Morley AJ, Viner J, Attwood M, Noel A, Gunning S, Hatrick J, Hamilton S, Elvers KT, Hyams C, Bibby A, Moran E, Adamali HI, Dodd JW, Maskell NA, Barratt SL. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax 2021;76:399&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>de Graaf MA, Antoni ML, Ter Kuile MM, Arbous MS, Duinisveld AJF, Feltkamp MCW, Groeneveld GH, Hinnen SCH, Janssen VR, Lijfering WM, Omara S, Postmus PE, Ramai SRS, Rius-Ottenheim N, Schalij MJ, Schiemanck SK, Smid L, Stoger JL, Visser LG, de Vries JJC, Wijngaarden MA, Geelhoed JJM, Roukens AHE. Short-term outpatient follow-up of COVID-19 patients: a multidisciplinary approach. EClinicalMedicine 2021;32:100731.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7843037</ArticleId><ArticleId IdType="pubmed">33532720</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A, Bernabei R, Landi F, Gemelli against COVID-19 Post-Acute Care Study Group . Persistent symptoms in patients after acute COVID-19. JAMA 2020;324:603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C, Laurent E, Lemaignen A, Beaufils E, Bourbao-Tournois C, Laribi S, Flament T, Ferreira-Maldent N, Bruyere F, Stefic K, Gaudy-Graffin C, Grammatico-Guillon L, Bernard L. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect 2021;27:258&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q, Xu M, Li J, Liu Y, Zhang J, Xu Y, Dong W. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect 2021;27:89&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, Doucet L, Berkani S, Oliosi E, Mallart E, Corre F, Zarrouk V, Moyer JD, Galy A, Honsel V, Fantin B, Nguyen Y. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect 2020;81:e4&#x2013;e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimoni O, Korenfeld R, Goland S, Meledin V, Haberman D, George J, Shimoni S. Subclinical myocardial dysfunction in patients recovered from COVID-19 disease: correlation with exercise capacity. Biology (Basel) 2021;10:1201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8615112</ArticleId><ArticleId IdType="pubmed">34827194</ArticleId></ArticleIdList></Reference><Reference><Citation>Kersten J, Baumhardt M, Hartveg P, Hoyo L, H&#xfc;ll E, Imhof A, Kropf-Sanchen C, Nita N, M&#xf6;rike J, Rattka M, Andre&#xdf; S, Scharnbeck D, Schmidtke-Schrezenmeier G, Tadic M, Wolf A, Rottbauer W, Buckert D. Long COVID: distinction between organ damage and deconditioning. J Clin Med 2021;10:3782.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8432179</ArticleId><ArticleId IdType="pubmed">34501230</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine S, Ibn Hadj Amor H, Jdidi J, Torjmen S, Kraiem S, Hammami R, Bahloul A, Kallel N, Moussa N, Touil I, Ghrab A, Elghoul J, Meddeb Z, Thabet Y, Kammoun S, Bouslama K, Milouchi S, Abdessalem S, Abid L. Long COVID 19 syndrome: is it related to microcirculation and endothelial dysfunction? Insights from TUN-EndCOV study. Front Cardiovasc Med 2021;8:745758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8670225</ArticleId><ArticleId IdType="pubmed">34917659</ArticleId></ArticleIdList></Reference><Reference><Citation>Pel&#xe0; G, Goldoni M, Cavalli C, Perrino F, Tagliaferri S, Frizzelli A, Mori PA, Majori M, Aiello M, Sverzellati N, Corradi M, Chetta A. Long-term cardiac sequelae in patients referred into a diagnostic post-COVID-19 pathway: the different impacts on the right and left ventricles. Diagnostics (Basel) 2021;11:2059.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8623572</ArticleId><ArticleId IdType="pubmed">34829406</ArticleId></ArticleIdList></Reference><Reference><Citation>Goertz YMJ, Van Herck M, Delbressine JM, Vaes AW, Meys R, Machado FVC, Houben-Wilke S, Burtin C, Posthuma R, Franssen FME, van Loon N, Hajian B, Spies Y, Vijlbrief H, van &#x2018;t Hul AJ, Janssen DJA, Spruit MA. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res 2020;6:00542&#x2013;2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Havervall S, Rosell A, Phillipson M, Mangsbo SM, Nilsson P, Hober S, Thalin C. Symptoms and functional impairment assessed 8 months after mild COVID-19 among health care workers. JAMA 2021;325:2015&#x2013;2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8027932</ArticleId><ArticleId IdType="pubmed">33825846</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingul CB, Grimsmo J, Mecinaj A, Trebinjac D, Berger Nossen M, Andrup S, Grenne B, Dalen H, Einvik G, Stavem K, Follestad T, Josefsen T, Omland T, Jensen T. Cardiac dysfunction and arrhythmias 3 months after hospitalization for COVID-19. J Am Heart Assoc 2022;11:e023473.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9238505</ArticleId><ArticleId IdType="pubmed">35048715</ArticleId></ArticleIdList></Reference><Reference><Citation>Arany&#xf3; J, Bazan V, Llad&#xf3;s G, Dominguez MJ, Bisbal F, Massanella M, Sarrias A, Adeli&#xf1;o R, Riverola A, Paredes R, Clotet B, Bay&#xe9;s-Gen&#xed;s A, Mateu L, Villuendas R. Inappropriate sinus tachycardia in post-COVID-19 syndrome. Sci Rep 2022;12:298.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8741896</ArticleId><ArticleId IdType="pubmed">34996973</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah B, Kunal S, Bansal A, Jain J, Poundrik S, Shetty MK, Batra V, Chaturvedi V, Yusuf J, Mukhopadhyay S, Tyagi S, Meenahalli Palleda G, Gupta A, Gupta MD. Heart rate variability as a marker of cardiovascular dysautonomia in post-COVID-19 syndrome using artificial intelligence. Indian Pacing Electrophysiol J 2022;22:70&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8800539</ArticleId><ArticleId IdType="pubmed">35101582</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra V, Flanders SA, O'Malley M, Malani AN, Prescott HC. Sixty-Day outcomes among patients hospitalized with COVID-19. Ann Intern Med 2021;174:576&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>Daher A, Balfanz P, Cornelissen C, Muller A, Bergs I, Marx N, Muller-Wieland D, Hartmann B, Dreher M, Muller T. Follow up of patients with severe coronavirus disease 2019 (COVID-19): pulmonary and extrapulmonary disease sequelae. Respir Med 2020;174:106197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7573668</ArticleId><ArticleId IdType="pubmed">33120193</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, Walshaw C, Kemp S, Corrado J, Singh R, Collins T, O'Connor RJ, Sivan M. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol 2021;93:1013&#x2013;1022.</Citation><ArticleIdList><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Buttery S, Philip KEJ, Williams P, Fallas A, West B, Cumella A, Cheung C, Walker S, Quint JK, Polkey MI, Hopkinson NS. Patient symptoms and experience following COVID-19: results from a UK-wide survey. BMJ Open Respir Res 2021;8:e001075.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8572361</ArticleId><ArticleId IdType="pubmed">34732518</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L, Drake TM, Pauley E, Jesudason EC, Olliaro P, Lim WS, Gillesen A, Berry C, Lowe DJ, McPeake J, Lone N, Munblit D, Cevik M, Casey A, Bannister P, Russell CD, Goodwin L, Ho A, Turtle L, O'Hara ME, Hastie C, Donohue C, Spencer RG, Donegan C, Gummery A, Harrison J, Hardwick HE, Hastie CE, Carson G, Merson L, Baillie JK, Openshaw P, Harrison EM, Docherty AB, Semple MG, Scott JT. Long COVID in adults discharged from UK hospitals after COVID-19: a prospective, multicentre cohort study using the ISARIC WHO clinical characterisation protocol. Lancet Reg Health Eur 2021;8:100186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerget B, &#xc7;elik E, Kerget F, Aksakal A, U&#xe7;ar EY, Araz &#xd6;, Akg&#xfc;n M. Evaluation of 3-month follow-up of patients with postacute COVID-19 syndrome. J Med Virol 2022;94:2026&#x2013;2034.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9015610</ArticleId><ArticleId IdType="pubmed">35001367</ArticleId></ArticleIdList></Reference><Reference><Citation>Duggal P, Penson T, Manley HN, Vergara C, Munday RM, Duchen D, Linton EA, Zurn A, Keruly JC, Mehta SH, Thomas DL. Post-sequelae symptoms and comorbidities after COVID-19. J Med Virol 2022;94:2060&#x2013;2066.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8958980</ArticleId><ArticleId IdType="pubmed">35032030</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, Bobkova P, Spiridonova E, Shikhaleva A, Gamirova A, Blyuss O, Nekliudov N, Bugaeva P, Andreeva M, DunnGalvin A, Comberiati P, Apfelbacher C, Genuneit J, Avdeev S, Kapustina V, Guekht A, Fomin V, Svistunov AA, Timashev P, Subbot VS, Royuk VV, Drake TM, Hanson SW, Merson L, Carson G, Horby P, Sigfrid L, Scott JT, Semple MG, Warner JO, Vos T, Olliaro P, Glybochko P, Butnaru D, Sechenov StopCOVID Research Team . Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19. Clin Exp Allergy 2021;51:1107&#x2013;1120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8444748</ArticleId><ArticleId IdType="pubmed">34351016</ArticleId></ArticleIdList></Reference><Reference><Citation>Luchian ML, Motoc A, Lochy S, Magne J, Belsack D, De Mey J, Roosens B, Van den Bussche K, Boeckstaens S, Chameleva H, Geers J, Houard L, De Potter T, Allard S, Weytjens C, Droogmans S, Cosyns B. Subclinical myocardial dysfunction in patients with persistent dyspnea one year after COVID-19. Diagnostics (Basel0) 2021;12:57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8775030</ArticleId><ArticleId IdType="pubmed">35054224</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorelli G, Braggio M, Gabbiani D, Busti F, Caminati M, Senna G, Girelli D, Laveneziana P, Ferrari M, Sartori G, Dalle Carbonare L, Crisafulli E. Importance of cardiopulmonary exercise testing amongst subjects recovering from COVID-19. Diagnostics (Basel) 2021;11:507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7998697</ArticleId><ArticleId IdType="pubmed">33809260</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladlow P, O'Sullivan O, Houston A, Barker-Davies R, May S, Mills D, Dewson D, Chamley R, Naylor J, Mulae J, Bennett AN, Nicol ED, Holdsworth DA. Dysautonomia following COVID-19 is not associated with subjective limitations or symptoms but is associated with objective functional limitations. Heart Rhythm 2022;19:613&#x2013;620.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8656177</ArticleId><ArticleId IdType="pubmed">34896622</ArticleId></ArticleIdList></Reference><Reference><Citation>Stella A B, Furlanis G, Frezza NA, Valentinotti R, Ajcevic M, Manganotti P. Autonomic dysfunction in post-COVID patients with and without neurological symptoms: a prospective multidomain observational study. J Neurol 2021;269:587&#x2013;596.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8359764</ArticleId><ArticleId IdType="pubmed">34386903</ArticleId></ArticleIdList></Reference><Reference><Citation>Shouman K, Vanichkachorn G, Cheshire WP, Suarez MD, Shelly S, Lamotte GJ, Sandroni P, Benarroch EE, Berini SE, Cutsforth-Gregory JK, Coon EA, Mauermann ML, Low PA, Singer W. Autonomic dysfunction following COVID-19 infection: an early experience. Clin Auton Res 2021;31:385&#x2013;394.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8050227</ArticleId><ArticleId IdType="pubmed">33860871</ArticleId></ArticleIdList></Reference><Reference><Citation>Bisaccia G, Ricci F, Recce V, Serio A, Iannetti G, Chahal AA, St&#xe5;hlberg M, Khanji MY, Fedorowski A, Gallina S. Post-acute sequelae of COVID-19 and cardiovascular autonomic dysfunction: what do we know? J Cardiovasc Dev Dis 2021;8:156.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8621226</ArticleId><ArticleId IdType="pubmed">34821709</ArticleId></ArticleIdList></Reference><Reference><Citation>Breitbart P, Koch A, Schmidt M, Magedanz A, Lindhoff-Last E, Voigtlander T, Schmermund A, Mehta RH, Eggebrecht H. Clinical and cardiac magnetic resonance findings in post-COVID patients referred for suspected myocarditis. Clin Res Cardiol 2021;110:1832&#x2013;1840.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8390029</ArticleId><ArticleId IdType="pubmed">34448040</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A, Wamil M, Alberts J, Oben J, Cuthbertson DJ, Wootton D, Crooks M, Gabbay M, Brady M, Hishmeh L, Attree E, Heightman M, Banerjee R, Banerjee A. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open 2021;11:e048391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel P, Thompson PD. Diagnosing COVID-19 myocarditis in athletes using cMRI. Trends Cardiovasc Med 2022;32:146&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8695309</ArticleId><ArticleId IdType="pubmed">34954013</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark DE, Dendy JM, Li DL, Crum K, Dixon D, George-Durrett K, Parikh AP, Wassenaar JW, Hughes SG, Soslow JH. Cardiovascular magnetic resonance evaluation of soldiers after recovery from symptomatic SARS-CoV-2 infection: a case&#x2013;control study of cardiovascular post-acute sequelae of SARS-CoV-2 infection (CV PASC). J Cardiovasc Magn Reson 2021;23:106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8495668</ArticleId><ArticleId IdType="pubmed">34620179</ArticleId></ArticleIdList></Reference><Reference><Citation>Malek LA, Marczak M, Milosz-Wieczorek B, Konopka M, Braksator W, Drygas W, Krzywanski J. Cardiac involvement in consecutive elite athletes recovered from COVID-19: a magnetic resonance study. J Magn Reson Imaging 2021;53:1723&#x2013;1729.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8014772</ArticleId><ArticleId IdType="pubmed">33474768</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen EL, Go&#xdf;ling A, Adam G, Aepfelbacher M, Behrendt CA, Cavus E, Cheng B, Fischer N, Gallinat J, K&#xfc;hn S, Gerloff C, Koch-Gromus U, H&#xe4;rter M, Hanning U, Huber TB, Kluge S, Knobloch JK, Kuta P, Schmidt-Lauber C, L&#xfc;tgehetmann M, Magnussen C, Mayer C, Muellerleile K, M&#xfc;nch J, N&#xe4;gele FL, Petersen M, Renn&#xe9; T, Riedl KA, Rimmele DL, Sch&#xe4;fer I, Schulz H, Tahir E, Waschki B, Wenzel JP, Zeller T, Ziegler A, Thomalla G, Twerenbold R, Blankenberg S. Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: the Hamburg city health study COVID programme. Eur Heart J 2022;43:1124&#x2013;1137.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8755397</ArticleId><ArticleId IdType="pubmed">34999762</ArticleId></ArticleIdList></Reference><Reference><Citation>Tudoran C, Tudoran M, Cut TG, Lazureanu VE, Oancea C, Marinescu AR, Pescariu SA, Pop GN, Bende F. Evolution of echocardiographic abnormalities identified in previously healthy individuals recovering from COVID-19. J Pers Med 2022;12:46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8778114</ArticleId><ArticleId IdType="pubmed">35055360</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassar MP, Tunnicliffe EM, Petousi N, Lewandowski AJ, Xie C, Mahmod M, Samat AHA, Evans RA, Brightling CE, Ho LP, Piechnik SK, Talbot NP, Holdsworth D, Ferreira VM, Neubauer S, Raman B. Symptom persistence despite improvement in cardiopulmonary health&#x2014;insights from longitudinal CMR, CPET and lung function testing post-COVID-19. EClinicalMedicine 2021;41:101159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8527025</ArticleId><ArticleId IdType="pubmed">34693230</ArticleId></ArticleIdList></Reference><Reference><Citation>Lakatos BK, Tokodi M, F&#xe1;bi&#xe1;n A, Lad&#xe1;nyi Z, V&#xe1;g&#xf3; H, Szab&#xf3; L, Syd&#xf3; N, Csulak E, Kiss O, Babity M, Kiss AR, Gregor Z, Sz&#x171;cs A, Merkely B, Kov&#xe1;cs A. Frequent constriction-like echocardiographic findings in elite athletes following mild COVID-19: a propensity score-matched analysis. Front Cardiovasc Med 2021;8:760651.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8767617</ArticleId><ArticleId IdType="pubmed">35071343</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambrosino P, Calcaterra I, Molino A, Moretta P, Lupoli R, Spedicato GA, Papa A, Motta A, Maniscalco M, Di Minno MND. Persistent endothelial dysfunction in post-acute COVID-19 syndrome: a case&#x2013;control study. Biomedicines 2021;9:957.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8391623</ArticleId><ArticleId IdType="pubmed">34440161</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejia-Renteria H, Travieso A, Sagir A, Mart&#xed;nez-G&#xf3;mez E, Carrascosa-Granada A, Toya T, N&#xfa;&#xf1;ez-Gil IJ, Estrada V, Lerman A, Escaned J. In-vivo evidence of systemic endothelial vascular dysfunction in COVID-19. Int J Cardiol 2021;345:153&#x2013;155.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8542397</ArticleId><ArticleId IdType="pubmed">34706286</ArticleId></ArticleIdList></Reference><Reference><Citation>Drakos S, Chatzantonis G, Bietenbeck M, Evers G, Schulze AB, Mohr M, Fonfara H, Meier C, Yilmaz A. A cardiovascular magnetic resonance imaging-based pilot study to assess coronary microvascular disease in COVID-19 patients. Sci Rep 2021;11:15667.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8329060</ArticleId><ArticleId IdType="pubmed">34341436</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T, Sahanic S, Pizzini A, Luger A, Schwabl C, Sonnweber B, Kurz K, Koppelstatter S, Haschka D, Petzer V, Boehm A, Aichner M, Tymoszuk P, Lener D, Theurl M, Lorsbach-Kohler A, Tancevski A, Schapfl A, Schaber M, Hilbe R, Nairz M, Puchner B, Huttenberger D, Tschurtschenthaler C, Asshoff M, Peer A, Hartig F, Bellmann R, Joannidis M, Gollmann-Tepekoylu C, Holfeld J, Feuchtner G, Egger A, Hoermann G, Schroll A, Fritsche G, Wildner S, Bellmann-Weiler R, Kirchmair R, Helbok R, Prosch H, Rieder D, Trajanoski Z, Kronenberg F, Woll E, Weiss G, Widmann G, Loffler-Ragg J, Tancevski I. Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial. Eur Respir J 2021;57:2003481 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7736754</ArticleId><ArticleId IdType="pubmed">33303539</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohiuddin Chowdhury ATM, Karim MR, Ali MA, Islam J, Li Y, He S. Clinical characteristics and the long-term post-recovery manifestations of the COVID-19 patients &#x2013; a prospective multicenter cross-sectional study. Front Med (Lausanne) 2021;8:663670.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8416537</ArticleId><ArticleId IdType="pubmed">34490284</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, Villapol S. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep 2021;11:16144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Chioh FW, Fong SW, Young BE, Wu KX, Siau A, Krishnan S, Chan YH, Carissimo G, Teo LL, Gao F, Tan RS, Zhong L, Koh AS, Tan SY, Tambyah PA, Renia L, Ng LF, Lye DC, Cheung C. Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation. Elife 2021;10:e64909.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7987341</ArticleId><ArticleId IdType="pubmed">33752798</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel SK, Juno JA, Lee WS, Wragg KM, Hogarth PM, Kent SJ, Burrell LM. Plasma ACE2 activity is persistently elevated following SARS-CoV-2 infection: implications for COVID-19 pathogenesis and consequences. Eur Respir J 2021;57:2003730.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7830336</ArticleId><ArticleId IdType="pubmed">33479113</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng M, Gao Y, Wang G, Song G, Liu S, Sun D, Xu Y, Tian Z. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol 2020;17:533&#x2013;535.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7091858</ArticleId><ArticleId IdType="pubmed">32203188</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng HY, Zhang M, Yang CX, Zhang N, Wang XC, Yang XP, Dong XQ, Zheng YT. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients. Cell Mol Immunol 2020;17:541&#x2013;543.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7091621</ArticleId><ArticleId IdType="pubmed">32203186</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul BD, Lemle MD, Komaroff AL, Snyder SH. Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome. Proc Natl Acad Sci U S A 2021;118:e2024358118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8403932</ArticleId><ArticleId IdType="pubmed">34400495</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollenberg R, Tepasse PR, Ochs K, Floer M, Strauss M, Rennebaum F, Kabar I, Rovas A, Nowacki T. Indications of persistent glycocalyx damage in convalescent COVID-19 patients: a prospective multicenter study and hypothesis. Viruses 2021;13:2324.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8619155</ArticleId><ArticleId IdType="pubmed">34835130</ArticleId></ArticleIdList></Reference><Reference><Citation>Heerdt PM, Shelley B, Singh I. Impaired systemic oxygen extraction long after mild COVID-19: potential perioperative implications. Br J Anaesth 2022;128:e246&#x2013;e249.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8710396</ArticleId><ArticleId IdType="pubmed">35067364</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiatkittikul P, Promteangtrong C, Kunawudhi A, Siripongsatian D, Siripongboonsitti T, Ruckpanich P, Thongdonpua S, Jantarato A, Piboonvorawong C, Fonghoi N, Chotipanich C. Abnormality pattern of F-18 FDG PET whole body with functional MRI brain in post-acute COVID-19. Nucl Med Mol Imaging 2022;56:29&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8760088</ArticleId><ArticleId IdType="pubmed">35069924</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>